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 ABSTRACT 
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WITH TYPE 1 DIABETES 
 
 
Christopher J. Fitzgerald, M.S. 
 
Marquette University, 2013 
 
Children and adolescents living with Type 1 Diabetes Mellitus (T1DM) face 
many challenges in their daily lives due to the extensive care tasks that the illness 
requires.  Adolescence is a period of development in which treatment adherence and 
metabolic control has been found to greatly decline.  Research examining correlates of 
this decline in self-management has tended to focus on familial and psychosocial 
variables such as parental involvement and T1DM-related conflict.  The period of 
adolescence is also marked by several changes in the development of the frontal lobes 
and prefrontal cortex, which are areas of the brain that are central to executive 
functioning abilities.  The present study will examine executive functioning among 
adolescents with T1DM to explore its relationship with treatment adherence, metabolic 
control, and with measures of family involvement in the management of T1DM.   
            
 Eighty four adolescents diagnosed with T1DM (ages 12-18) and their parents 
completed the study.  Parents and adolescents completed questionnaires assessing 
adolescents’ executive functioning, parental involvement, monitoring, and conflict. 
Adolescents completed neuropsychological measures assessing several aspects of their 
neuropsychological functioning including their executive functioning, intelligence, and 
memory.  In addition to this, adolescents’ medical records were reviewed to collect 
hemoglobin A1c (HbA1c) values, which represent levels of metabolic control. 
   
In general, results supported our hypotheses, in that adolescents with better 
developed parent and self-reported executive functions tended to display better adherence 
to their T1DM treatment regimen.  Additionally, parent and self-reports of adolescent 
executive functioning were shown to be significant predictors of adherence beyond the 
contributions of several demographic and family functioning variables.  Examination of 
parents’ contributions to adolescents’ T1DM management revealed that parental 
involvement was a significant moderator of the relationship between adolescents’ 
executive functioning and treatment adherence, such that parental involvement had a 
larger impact for adolescents who demonstrated poorer executive functions.   
  
Overall, the study finds support for measuring executive functioning abilities in 
adolescents with T1DM as a potentially important contributing factor in aiding 
adolescents with the complex management of this illness.  
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An Examination of the Role of Neurocognitive Functioning in Illness Management 
Among Adolescents With Type 1 Diabetes 
Children and adolescents living with type 1 diabetes mellitus (T1DM) face many 
challenges in their daily lives due to the extensive care tasks that their illness often 
requires.  During the adolescent years, youth are particularly at risk for many of the 
complications that accompany poor treatment adherence (Anderson, Auslander, Jung, 
Miller, & Santiago, 1990).  Many of the difficulties that adolescents encounter with 
treatment adherence appear to be correlated with specific challenges experienced in 
relation to several cognitive, psychological, and social changes that occur throughout 
adolescence.  There are several salient factors that have been demonstrated to be 
significant predictors of treatment adherence and metabolic control.  Specifically, some 
of the social and psychological factors include the amount of parental involvement in 
T1DM management, parental monitoring of adherence behaviors, and T1DM- related 
conflict that is present within the family (Ellis, Podolski, Frey, Naar-King, Wang, & 
Moltz, 2007; Miller-Johnson et al., 1994; Palmer, Berg, Wiebe, Beveridge, & Korbel, 
2004).   
Adolescence is also a period in which certain areas of the brain show significant 
changes and development.  Specifically, the most dramatic changes have been found to 
occur within the frontal lobes and prefrontal cortex, which are areas of that brain that are 
responsible for executive functioning abilities (Blakemore & Choudhury, 2006).  
Executive functioning, which involves an individual’s ability to plan, self-monitor, and 
use working memory, has been studied extensively along with other related cognitive 
abilities in children with T1DM.  Although research has demonstrated that children and 
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adolescents with T1DM display moderately worse executive functioning abilities when 
compared to healthy controls, there has been little research examining the functional 
outcomes associated with these deficits (Gaudieri, Greer, Chen, & Holmes, 2008).  Given 
the complexity of the diabetes treatment regimen, executive functions likely encompass 
many of the skills that are needed in order for individuals to successfully manage all of 
the self-care tasks that they are supposed to maintain.   
Overall, there appears to be an established body of literature examining the 
psychological and social factors that account for poor treatment adherence during 
adolescence; however, there has been little research examining how cognitive functioning 
may impact treatment adherence and metabolic control.  The current study will also 
further explore the multifaceted ways in which the family contributes to T1DM 
management among adolescents while taking into account adolescents’ incomplete 
cortical development and evolving cognitive capacity.  
Type 1 Diabetes Mellitus 
 
T1DM is the second most prevalent chronic illness among children and 
adolescents in the United States, and it affects one in 500-600 children (Wysocki, Greco, 
& Buckloh, 2003).  T1DM is characterized by the autoimmune destruction of pancreatic 
beta cells that results in an inability of the body to produce insulin, which is a hormone 
that facilitates the metabolic breakdown of glucose in the blood.  Glucose is a primary 
source of our body’s energy, comes from the food we consume, and can include complex 
carbohydrates or starches and fast-acting, simple sugars.  When carbohydrates are 
consumed, they are absorbed by the gastrointestinal tract and carried throughout the 
bloodstream to provide the body’s cells with the energy they need to function.  However, 
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in order for glucose to permeate the cell membrane, the hormone insulin must be present 
to facilitate this process (Beaser, 2007).  Insulin is manufactured in the pancreas, which is 
an organ that serves as part of the small intestines and lies below the stomach.  Within the 
pancreas, insulin is produced in the islets of Langerhans, which contain pancreatic beta 
cells.  These cells serve a regulatory function by secreting the appropriate amount of 
insulin in response to the concentration of glucose detected in the blood.  This autonomic 
response typically occurs in healthy individuals within 15 minutes after food 
consumption and is accurate within 2 mg/dl of the precise amount of insulin that is 
required (Watkins, Drury, & Howell, 1996).  In individuals with T1DM, the body’s 
autoimmune defenses, which usually target foreign substances such as viruses, attack the 
pancreatic beta cells and prevent the body from producing insulin.  The body begins to 
essentially starve itself because the cells are not able to metabolize the sugars for energy.  
This results in severely high levels of glucose in the blood, which is a condition known as 
hyperglycemia (Beaser, 2007).  
T1DM, which previously was called juvenile onset diabetes, typically is 
diagnosed in childhood and has a mean age of onset between 9 and 15 years of age 
(Watkins et al., 1996).  The disease is typically diagnosed following symptoms of 
polyurea, polydipsea, and polyphagia as well as weight loss and fatigue.  Many families 
do not seek immediate treatment for these symptoms due to their resemblance to the 
common flu.  Hyperglycemia (>126 mg/dl on repeated measures over time) must be 
established in order to make a diagnosis (American Diabetes Association, 2008).  If 
insulin is not administered to these patients, they will experience diabetic ketoacidosis 
(DKA), which is a condition in which the body begins to break down fatty acids in the 
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liver.  This process results in the secretion of ketones into the bloodstream, which 
provides energy for the brain but lowers the pH of the blood to acidic levels.  Patients in 
DKA experience nausea and vomiting, and if they are not treated for an extended period 
of time, the symptoms can eventuate to a state of coma or death (Beaser, 2007).   
Following diagnosis of T1DM, there is an intensive level of daily care tasks that 
must be completed, which include blood glucose monitoring several times per day, 
administering insulin injections with respect to the type and amount of food eaten, as well 
as maintaining a strict diet and engaging in regular exercise (Greening, Stoppelbein, & 
Reeves, 2006).  Because of the variable nature of the illness and frequently changing 
insulin requirements, children and adolescents with T1DM often experience 
modifications in their treatment regimen several times per year.  To assess the level of 
metabolic control patients maintain, physicians obtain a measurement of the amount of 
glycosylated hemoglobin (HbA1c) that is present in the blood.  HbA1c reflects the average 
level of blood glucose control the individual has maintained over the previous 6-8 weeks.  
Higher numbers reflect poorer control.  The average healthy individual has an HbA1c 
value of less than 6.5%, but this is usually higher in individuals with diabetes, who aim to 
maintain a value less than or equal to 7.4% (American Diabetes Association, 2008).  If 
proper care is not maintained, there are several short-term consequences that include 
ketoacidosis as well as hyper- and hypoglycemic (state of severely low, < 50mg/dl, blood 
glucose levels) episodes.  There can be severe consequences to ill-maintained T1DM.  
Long-term effects include, but are not limited to, restricted joint mobility, heart disease, 
blindness, and early death (Beaser, 2007).   
Treatment Adherence 
5 
 
 
 Patient adherence to medical treatment regimen is an area of study that has gained 
increasing interest over the past few decades.  There are many definitions of what 
constitutes treatment adherence, but one of the most widely accepted definitions was 
provided by Haynes (1979) who described treatment adherence as “the extent to which a 
person’s behavior (in terms of taking medications, following diets, or executing lifestyle 
changes) coincides with medical or health advice” (p. 2).  Over the years, the terms used 
to describe this construct have changed to reflect a more active role on the part of the 
patient.  Early adherence research used the term “treatment compliance,” which connotes 
a sense of blind obedience to the recommendations of the provider.  The term 
“adherence” is now used to describe this construct and implies a more collaborative 
relationship among the patient and physician in which each party plays an active role in 
planning and implementing a treatment regimen that will work best for the individual’s 
needs (Myers & Midence, 1998).  Although physicians serve as the experts who impart 
recommendations to patients regarding the best course of treatment, the decision to 
adhere is ultimately up to the patient to decide whether or not he/she will implement the 
recommendations.  For children and adolescents with chronic illnesses, this responsibility 
falls not only on the child but also on the parents to manage within a family context 
(Anderson et al., 1990; Rapoff, 2010).   
Adherence can be viewed as a categorical or a dimensional construct.  Although 
much of the research has examined it categorically, meaning that individuals are judged 
to be either adherent or nonadherent, this approach is limiting because of the subjectivity 
inherent to labeling self-care behaviors.  There is no single definition for determining 
what constitutes adequate adherence, and thus it is best understood as a dimensional 
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construct in which individuals may be fully or partially adherent to various aspects of the 
treatment regimen (LaGreca & Bearman, 2003).  Due to the inexact medical science that 
is involved in chronic illness management, adherence behaviors are never perfectly 
correlated with symptom relief or maintaining illness control.  Research has widely 
demonstrated that there is a moderate relationship between treatment adherence and 
illness control for the management of most chronic illnesses (e.g. DiMatteo, Giordani, 
Lepper, & Croghan, 2002; Johnson, 1994).  Consequently, nonadherence has proven to 
be a major health concern in the United States both in minor as well as major health 
conditions.  Overall rates of adherence across all medical conditions are believed to be 
less than 50% and represent a major public health issue in America.  Nonadherence to 
medical regimen is estimated to cost about 100 billion dollars every year due to 
unnecessary hospitalizations and additional diagnostic tests and medication (DiMatteo, 
2004; Rapoff, 2010).   
Although the principles of adherence are similar across illness conditions, there is 
significant variability across illness groups in terms of the treatment regimen 
requirements.  For patients with chronic health conditions such as T1DM, adherence is 
even lower than it is for less pervasive, acute health conditions, despite the consequences 
of nonadherence usually being much more severe (Christensen, 2004).  Among chronic 
health conditions there are differences in treatment adherence as well, with disease 
chronicity serving as a significant correlate of treatment adherence (Rapoff, 2010).  
About 50% of children with asthma improve their illness status as a direct effect of their 
treatment compliance and are asymptomatic as adolescents (Lemanek, 1990).  This is in 
sharp contrast to children and adolescents who are diagnosed with T1DM, whose 
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treatment compliance is aimed at managing the symptoms of a lifelong illness, and 
consequently they tend to display poorer treatment adherence (LaGreca & Bearman, 
2003).  
T1DM is one of the most psychologically and physically demanding chronic 
illnesses to care for due to the multitude of interdependent tasks that are required (Cox & 
Gonder-Frederick, 1992).  For individuals to maintain adequate control of their T1DM, 
they are typically instructed to check their blood glucose (BG) values 4-6 times per day 
(American Diabetes Association, 2008).  From the value that these BG checks yield, 
individuals are expected to make adjustments, either by dosing the proper amount of 
insulin to bring their BG value down or by consuming a fast-acting sugar to bring their 
BG up into the desired range.  Other requirements of the T1DM treatment regimen 
include following dietary restrictions while making sure to measure the grams of 
carbohydrates consumed in every serving to ensure the proper dose of insulin that must 
be administered.  It is also important to engage in daily exercise to help the body to 
regulate its BG levels (Johnson, 1993).   
Research has provided support for the interrelatedness among some components 
of the treatment regimen.  One study (Glasgow, McCaul, & Schafer, 1987) found that 
when individuals experienced difficulties following dietary recommendations, they also 
tended to be less adherent to their BG monitoring and insulin administration as well.  
These tasks are directly related to one another and involve a certain level of planning and 
coordination to complete.  Interestingly, there was no relationship found among these 
aspects of the treatment regimen (i.e. patient adherence to diet, blood glucose monitoring, 
and insulin administration) and the amount of exercise in which the youth engaged in.  
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This finding suggests that some of the tasks may be more difficult to perform either due 
to their complexity and time requirements or because they are duties that parents have 
more responsibility for maintaining.  Exercise is one aspect of the treatment regimen than 
does not require extensive planning.  Findings such as this speak to the importance of 
studying the various aspects of the treatment regimen separately to determine which 
components of treatment are the most difficult to adhere to.   
Given the subjective nature of treatment adherence, there have been several 
methods utilized to measure this nebulous construct.  Some of these methods of assessing 
adherence include self-report questionnaires, structured interviews, diary methods, and 
electronic monitors.  Although metabolic control, as measured by HbA1c values, is 
sometimes used as a measures of adherence, it is actually a measure of outcome, rather 
than a measure of process (Kyngas, Kroll, & Duffy, 2000).  There has been a significant 
amount of evidence demonstrating a strong correlation between adherence behaviors and 
HbA1c values (Hood, Peterson, Rohan, & Drotar, 2010).  Yet, this significant relationship 
is not always found due to many other biological and psychosocial factors that contribute 
to HbA1c values.  It is important for research studies to examine the quality of treatment 
adherence as well as levels of metabolic control to gain a comprehensive picture that 
includes both the process of self-care as well as the outcome of it.   
Despite the variety of methods of measuring adherence and the multitude of 
research that has been conducted examining the efficacy of each, there still does not 
appear to be a “gold standard” approach to assessing adherence (Quittner, Espelage, 
Ievers-Landis, & Drotar, 2000).  Quittner and colleagues (2008) have suggested that 
research assessing treatment adherence should use at least two different methods of 
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assessment (i.e., self-report questionnaires, daily diaries, or physiological measures), yet 
much of the research in this area fails to include multiple measures, primarily due to the 
practical challenges inherent to additional measurement.   A multi-assessment method 
corrects for some of the biases that are associated with the biological (i.e. hormonal 
influence), as well as self-reported (i.e., social desirability of responses) evaluations of 
adherence.   
Treatment Adherence and Metabolic Control Among Adolescents With T1DM 
 
Adolescence is a period of development that is generally associated with the 
lowest levels of treatment adherence and metabolic control across the lifespan (Anderson, 
et al., 1990; Miller-Johnson et al, 1994) with hospitalizations and episodes of 
ketoacidosis being most prevalent during middle adolescence (Glasgow et al., 1991).  
One study (Weissberg-Benchell et al., 1995) examining adolescents’ adherence to a 
T1DM treatment regimen found that 29% of adolescents had missed blood glucose tests, 
29% had falsified blood glucose test results, and 25% had skipped their insulin doses.  
Adolescents endorsed several reasons for this mismanagement, which included forgetting 
about their T1DM management tasks, not feeling that the care tasks were necessary or 
important, or acting oppositionally in response to the pressure they felt from physicians 
and family members to maintain good levels of control.  What was even more concerning 
than the levels of mismanagement that adolescents displayed was the vast underreporting 
of mismanagement behaviors by their parents, which demonstrates a lack of parental 
involvement or monitoring.  There has been a significant amount of research examining 
the salient family factors that are correlated with adolescent mismanagement.  Specific 
factors that have been found to be related to poor treatment adherence during this 
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developmental period include the amount of parental involvement and parental 
monitoring of adolescents’ T1DM management and the amount of parent-adolescent 
conflict that is experienced in the home. 
     Parental involvement in adolescents’ T1DM management. 
 
The family plays an important role in helping adolescents successfully manage 
their T1DM.  Due to the complexities of the treatment regimen, parents assume most of 
the responsibility for care tasks in early childhood because children and preadolescents 
do not possess the cognitive maturity it takes to plan for and organize a flexible diabetes 
regimen (Golden, 1999).  However, during adolescence, a transition in care responsibility 
occurs in which parents begin to encourage adolescents to become more autonomous 
with their illness tasks (Weissberg-Benchell, Wolpert, & Anderson, 2007).  During this 
transitional period, parents abdicate some of the responsibility for maintaining 
adolescents’ T1DM tasks, and there is an expectation that youth will begin taking more 
responsibility accordingly.  However, this process is not as synchronous as parents and 
providers often believe it will be.  Although research has demonstrated the benefits of 
shared illness management throughout adolescence (Helgeson, Reynolds, Siminerio, 
Escobar, & Becker, 2008), in an environment with shared responsibilities, there may not 
always be clear expectations about who is responsible for which tasks (Dashiff, 2003).   
     The care transition among parents and adolescents is most often not a one-time 
event in which responsibilities are handed over from one individual to the other.  Instead, 
the transition is a much more involved process in which parents and adolescents learn to 
negotiate the care regimen in concert with one another in a collaborative partnership.  
According to individuation theory, parents and their children have relationships that 
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drastically change during the adolescent years (Youniss & Smollar, 1985).  Adolescents 
learn to become autonomous through changes in the parent-child relationship which 
encourage their attempts towards the mastery of psychological, emotional, and behavioral 
tasks (Barber, 2002).  When the child is young the relationship is unilateral in nature; 
however, as the child enters adolescence, it becomes more egalitarian.  It is not an 
adolescent’s separation from his/her parents that allows him/her to become autonomous, 
rather, autonomy development is rooted in a reciprocal relationship between the parent 
and adolescent, which fosters an environment of acceptance and individuation (Noack & 
Buhl, 2005).  Individuation theory is directly applicable to the care of T1DM, which is 
most successfully managed within a family context.  Research has widely demonstrated 
that maintaining parental involvement throughout adolescence is associated with a variety 
of positive outcomes related to T1DM management (e.g. Anderson et al., 1990; 
Anderson, Ho, Brackett, Finkelstein, & Laffel, 1997; Helgeson et al., 2008).  Adolescents 
who are fully autonomous with their T1DM management are more likely to display 
poorer treatment adherence and poorer diabetes knowledge and have more T1DM-related 
complications and hospitalizations (Wysocki et al., 1996).   
The majority of studies examining care transition and familial management during 
adolescence have been cross-sectional, which limits the conclusions that can be drawn in 
determining pathways of effect.  Helgeson and colleagues (2008) conducted a two-year 
longitudinal study which provided evidence that sharing illness care responsibilities 
between parents and adolescents makes a significant impact on the psychological and 
physical health of adolescents with T1DM.  A greater amount of adolescent-perceived 
parent-youth shared responsibility predicted less depression among adolescents, higher 
12 
 
diabetes self-efficacy, and better levels of metabolic control.  The positive effects of 
shared responsibility were consistent throughout the adolescent years but were especially 
prevalent during later adolescence.  This provides strong evidence for the benefits of 
shared illness management among parents and adolescents not only early in the care 
transition process but also throughout adolescence.   
Maintenance of T1DM care requires complex physical and mental processes 
which involve resourceful decision making and complex planning behaviors in order to 
maintain diabetes control (DCCT, 1994).  Certain aspects of the T1DM regimen require 
more of this advanced cognitive ability.  A study examining the development of the 
Diabetes-Specific Parental Support for Autonomy Scale demonstrated that the only 
parental support behavior related to adolescents’ autonomy development was the sharing 
of insulin administration responsibilities, which is the task that represents the most 
complex skill (Hanna, DiMeglio, & Fortenbury, 2005).   It is possible that adolescents 
become overwhelmed when they are burdened by the responsibilities associated with 
many T1DM care tasks in a manner that is unshared and unsupervised by parents, which 
may lead to negative psychosocial outcomes and inadequate treatment adherence.   
     Parental monitoring of adolescents’ T1DM management. 
 
Shared T1DM management among parents and adolescents can take many 
different forms.  Parents can serve as models for adolescents in taking care of the 
majority of illness tasks, parents and adolescents can share the care tasks equally, or 
parents can be more removed and observe adolescents’ self-care to ensure completion 
and accuracy.  The latter approach refers to parental monitoring behavior, which is a 
construct of interest that has recently received more attention in the study of adolescent 
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T1DM management.  Parental monitoring includes behaviors that range from obtaining 
information about a child’s activities to direct oversight of those activities (Ellis, 
Templin, Naar-King, & Frey, 2008) and has been associated with positive academic 
outcomes (Rodgers & Rose, 2001) and reduced alcohol and drug abuse (Li, Stanton, & 
Feigelman, 2000).  Monitoring is different from parental involvement, which has been 
frequently studied among adolescents with T1DM and typically involves measuring the 
amount of instrumental care the parent is providing to the child (Anderson et al., 1990; 
Wysocki & Gavin, 2006).  When parents monitor self-care behaviors, it encourages 
adolescents to autonomously manage their T1DM care tasks while parents provide a 
phased and supported transition of care (Ellis et al., 2007).   
Research examining the role of parental monitoring of T1DM care tasks during 
adolescence has demonstrated that mothers’ and fathers’ reports of T1DM monitoring 
behaviors are positively associated with adolescent treatment adherence and indirectly 
related to metabolic control.  These associations were not found for general parental 
monitoring behaviors.  Additionally, parental monitoring accounted for a significant 
amount of variance in predicting adolescents’ treatment adherence beyond the 
contribution of parental support for T1DM care (Ellis et al., 2007).   
Parental involvement and monitoring of diabetes care are constructs that have 
demonstrated efficacy as predictors of adolescent treatment adherence.  There does not 
appear to be any research examining the role of parental involvement or monitoring of 
T1DM care tasks with regard to adolescents’ cognitive maturity.  Given the advanced 
cognitive skills necessary to maintain a flexible T1DM regimen, some adolescents who 
are more cognitively developed may have a distinct developmental advantage in planning 
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and coordinating their self-care.  Conversely, adolescents who have poorer cognitive 
functioning may benefit from a delayed care transition and additional parental 
involvement in order to successfully manage the complex T1DM regimen that the illness 
requires.  Further research is warranted to determine the mechanisms through which 
parental involvement or monitoring is effective at maintaining adequate treatment 
compliance and to examine the characteristics of children and adolescents for whom 
these types of parental involvement are most beneficial.   
     Parent-adolescent conflict surrounding T1DM care tasks. 
 
The adolescent years are a time prone to increased levels of conflict among 
adolescents and their parents (Laursen, 1993).  Conflict typically occurs with greater 
frequency and intensity during middle to late adolescence and plays a normative function 
according to most developmental theories.  Intense and sustained conflict among parents 
and adolescents has been associated with delinquency and oppositional behavioral 
disorders (Patterson, Capaldi, & Bank, 1991).  However, conflict that occurs in a 
constructive manner within an accepting home environment has been shown to be 
beneficial for teaching adolescents conflict resolution skills and appropriate affect 
regulation (Cooper, 1988).  During the adolescent years, a primary challenge for youth 
involves their development of a sense of independence and self-management.  This 
priority for adolescents often becomes an area of conflict between adolescents and their 
parents, as parents have to decide how much responsibility to abdicate and how much to 
maintain.   
The adolescent years can be a time of increased exposure to a variety of stressors 
in a youth’s life, especially those related to school, peer, and family functioning.  
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Research has shown that a majority of the conflicts that are experienced by parents and 
healthy adolescents revolve around everyday issues related to self-care, chores, and other 
responsibilities (Montemayor & Hanson, 1985).  For youth with T1DM, this parent-
adolescent stress may be exacerbated due to the tension created by the additional 
diabetes-related care responsibilities that are shared everyday (Miller-Johnson et al., 
1994).  Despite the additional stress created by a chronic illness diagnosis, research has 
demonstrated comparable levels of family conflict with regard to frequency and intensity 
in homes of healthy adolescents and in homes of adolescents with T1DM (Viikinsalo, 
Crawford, Kimbrel, Long, & Dashiff, 2005).   Although there does not appear to be 
additional conflict in homes of adolescents with T1DM, there is potentially more serious 
consequences to the conflict that does occur.  A greater frequency of family conflict 
experienced among parents and adolescents with T1DM has been shown to be related to 
poorer quality of life, whereas higher family social support has been related to better 
quality of life and better treatment adherence (Pereira, Berg-Cross, Almeida, & Machado, 
2008).   
The overall family environment during the adolescent years appears to play a 
significant role in shaping adolescents’ self-care behaviors.  Specifically, diabetes-related 
family conflict has been shown to be one of the best predictors of poor treatment 
adherence in adolescents with T1DM (Jacobson et al., 1994).   Several studies have 
demonstrated that parent-adolescent conflict is negatively related to youth’s metabolic 
control and positively related to youths’ treatment adherence (Anderson et al., 2002; 
Anderson et al., 2009; Miller-Johnson et al., 1994; Miller & Drotar, 2003).   In one study 
(Miller-Johnson et al., 1994), researchers found a significant association between conflict 
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and treatment adherence/metabolic control, but they failed to find any significant 
relationships among several other family environment variables, which included parent 
discipline, parental warmth, or behavioral support and treatment adherence or metabolic 
control.  There is also evidence that the care transition period that occurs during 
adolescence, as discussed earlier, is also related to diabetes-related family conflict.  When 
adolescents are more independent in their T1DM care tasks, they appear to exhibit higher 
levels of conflict with their parents (Schilling, Knafl, & Grey, 2006).  It is possible that 
this conflict is due to the negotiation of responsibility sharing that takes place when 
adolescents begin to take more responsibility, as well as the frustrations that may be 
experienced as a result of autonomous management.  Greater discrepancy of mothers’ 
and adolescents’ perceptions of responsibility sharing has also been significantly 
associated with increased conflict (Miller & Drotar, 2003).   
Development of the Adolescent Brain 
 
 Along with many of the psychological and social changes that occur throughout 
the adolescent years, there is increasing evidence that this is also a period of significant 
cortical development as adolescents experience marked changes in brain regions 
associated with response inhibition, calibration of risk and reward, and emotion 
regulation (Steinberg, 2005).  Although some of the changes in connectivity within the 
brain occur simultaneously with the hormonal changes associated with puberty, there is 
not a perfect relationship among the two (Dahl, 2001).  Most of these changes occur 
within the structures of the developing prefrontal cortex, but there are also connections 
created from the prefrontal cortex to other regions of the brain.  Many of these 
connections are to the limbic system, which affect the way that adolescents evaluate and 
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react to situations involving risk and reward (Spear, 2000).  Research has demonstrated 
that there are two structural changes that occur in the prefrontal cortex during 
adolescence (Blakemore & Choudhury, 2006).  The first change involves myelination of 
the neurons within this region of the brain.  Myelin serves as insulation for the axons of 
neurons and acts to speed the transmission of neural impulses by as much as 100 times 
that of unmyelinated neurons.  Although other neurons within the body, such as motor 
and sensory neurons, become myelinated in the first few years of life, it appears that this 
process is delayed in the neurons of the prefrontal cortex (Yakovlev & Lecours, 1967).  
Another developmental change that has been noted to occur within the prefrontal cortex 
is a process known as synaptogenesis.  This process, which is designed to make the brain 
a more efficient machine, involves the systematic pruning of neural connections.  As a 
result, frequently-used pathways are strengthened and infrequently- used connections are 
terminated thus eliminating inefficient pathways (Blakemore & Choudhury, 2006; Rakic, 
Bourgeois, & Goldman-Rakic, 1994).   
Extensive cellular research has examined this increased myelination and synaptic 
proliferation within the neurons of the prefrontal cortex during adolescence.  More 
recently, research using Magnetic Resonance Imaging (MRI) has supported this early 
work and has demonstrated that when comparing young children to adolescents, there is a 
higher percentage of white matter (which represents myelination on an MRI scan) in 
adolescents’ prefrontal cortices and a higher percentage of gray matter in the prefrontal 
cortices of younger children (e.g., Sowell et al., 1999; Sowell et al., 2003).  Despite these 
findings, there remains no clear consensus as to whether these MRI findings are a result 
18 
 
of increased myelination, synaptic pruning, or a combination of both of these processes 
(Paus, 2005).   
Longitudinal research examining cortical development among a group of children 
and adolescents aged 3-15 has also demonstrated a decrease in gray matter from 
childhood through adolescence in the dorsal frontal cortex (Thompson et al., 2000).  This 
decrease in gray matter and subsequent increase in white matter, as viewed through MRI 
scans, has also been shown to coincide with the onset of puberty (Giedd et al., 1999).  It 
appears that there are significant changes within the structures of the prefrontal cortex 
that occur throughout adolescence and increasing evidence that this development may 
transpire into the mid 20’s (Giedd, 2004; Sowell et al., 2001).  Giedd (2004) found 
through a longitudinal study design that the last area of the brain to develop was the 
dorsal lateral prefrontal cortex (DLPC), which did not fully develop until the early 20’s.  
The DLPC is an area of the brain that is responsible for individuals’ abilities to inhibit 
impulses, strategize, and weigh risk and reward decisions.  These cognitive abilities have 
been studied extensively through imaging and neuropsychological research to further 
examine how this late neural development affects adolescents’ day to day functioning.  
Some of the areas of cognitive functioning that have been studied include attention, 
memory, intelligence, and executive functioning.  
Development of Executive Functioning  
 
Executive functioning is defined as “a collection of interrelated functions, or 
processes, which are responsible for goal-directed or future-oriented behavior, and has 
been referred to as the ‘conductor’ which controls, organizes, and directs cognitive 
activity, emotional responses, and behavior” (Anderson, 2008, p. 4).  In general, 
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executive functioning involves the processes that are necessary for individuals to develop 
a goal or plan, execute the plan, and finally, to evaluate the outcome (Luria, 1973).  There 
have been several conceptual models proposed to help explain the functions of the 
executive system, but none are universally accepted (Anderson, 2008; Willcutt, Doyle, 
Nigg, Faraone, & Pennington, 2005).  Early models proposed that executive functioning 
was best understood by a unitary concept or “central executive” (Baddeley, 1986).  There 
has been intense debate over whether executive functioning exists as a unitary of 
multidimensional construct.  Much of this controversy has arisen as a result of increasing 
evidence that individuals rarely display gross executive dysfunction and due to the results 
of factor analytic studies which have identified multiple factors within executive 
functioning (Anderson, 2008).  There are several models used to understand executive 
functioning abilities (i.e., Lezak, 1995; Norman & Shallice, 1986; Zelazo, Carter, 
Reznick, & Frye, 1997).  Executive functioning is often measured through various 
cognitive components or abilities, which include planning and goal setting, generating 
ideas to solve a problem, initiation, behavioral inhibition, set shifting and cognitive 
flexibility, and working memory (Niloufar Salimpoor & Desrocher, 2006). 
Neuropsychological research examining executive functioning abilities among 
adolescents has suggested that these abilities may be particularly poor at the beginning of 
puberty (age 9-12) when the synaptogenesis of neural circuits begins in the prefrontal 
cortex.  Although this process increases the efficiency with which the neurons 
communicate in the prefrontal cortex over the course of adolescence, this initial 
proliferation of synapses that occurs at the beginning of puberty appears to have the 
opposite effect and may lead to worse executive functioning abilities.  Following the 
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onset of puberty, executive functioning abilities tend to increase in a linear manner 
throughout adolescence (McGivern, Andersen, Byrd, Mutter, & Reilly, 2002). 
Given that some models of executive functioning examine its various cognitive 
components, much of the research examining executive functioning has followed suit.  
When examining the period of preadolescence, there appear to be modest gains in set-
shifting, selective attention, and impulsive responding in children as early as ages 8-10, 
but development of more advanced executive abilities such as working memory and 
strategic planning showed greater development throughout middle to later adolescence 
(Klimkeit, Mattingley, Sheppard, Farrow, & Bradshaw, 2004; Luciana & Nelson, 2002).  
It is possible that the greater cognitive flexibility that comes with adolescence may 
initially be an encumbrance to adolescents as they are analyzing information to begin a 
problem solving task.  Adolescents often make several errors in their judgments and may 
overanalyze information as they learn to navigate problem solving tasks with new sets of 
skills (Anderson, 2002).  Consistent with the evolutionary course of development of the 
entire cortex, the prefrontal cortex appears to follow the same trajectory with simpler 
skills developing before those that are more complex.  Primitive executive skills such as 
attending and impulse control develop first, and more cognitively advanced skills sets 
such as strategic planning and prospective memory develop later in adolescence (as 
reviewed in Anderson, Anderson, Jacobs, & Smith, 2008).  
There are multiple ways through which the basic components of executive 
functioning, as described above, are assessed in research as well as in clinical settings.  
One method of assessment involves asking individuals about their executive functioning 
abilities by listing several tasks and assessing the level of difficulty experienced with 
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each.  This method usually involves a structured interview or self-reported questionnaire.  
Another method of assessment involves the use of neuropsychological measures of 
executive functioning.  The primary advantage to the neuropsychological measures is that 
they provide an objective measure of executive functioning, and they have significantly 
lower face validity than the interview or questionnaire methods.  However, despite the 
“gold standard” nature of these tests, there are several problems that exist with these 
measures, which include the multifactorial nature of the tests, issues with the 
generalizability of the tests to real life situations, and a general lack of sufficient 
normative samples for many ethnic minority groups (Kinsella, Storey, & Crawford, 
2006).  Due to these shortcomings, it is recommended that researchers and clinicians 
utilize a multilevel assessment of executive functioning, which typically involves the use 
of neuropsychological measures as well as self- and caregiver-report measures.  
Questionnaire measures of executive functioning offer an advantage in that they assess 
executive functions in multiple environments such as home and school (Kinsella et al., 
2006; Niloufar Salimpoor & Desrocher, 2006).  This multilevel assessment method, 
which includes neuropsychological measurement of several domains of executive 
functioning as well as questionnaires that provide data from multiple settings, appears to 
provide the most comprehensive assessment of cognitive functioning (McCloskey, 
Perkins, & Van Divner, 2009).   
Neurocognitive Functioning in Children and Adolescents with T1DM 
 
Given the psychobiological strain that T1DM places on the body through the 
variability in blood glucose levels, it is worth exploring the effects that the illness has on 
the cognitive functioning of children and adolescents.  As reviewed earlier, adolescence 
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is a period in which treatment adherence and metabolic control among youth with T1DM 
is particularly poor (e.g. Anderson et al., 1990).  Since research has demonstrated that 
adolescents’ executive functioning abilities are the poorest at the beginning of 
adolescence and slowly develop throughout the teenage years, this may provide some 
insight into the challenges that adolescents face when beginning to independently manage 
their T1DM cares (McGivern et al., 2002).   
 There are many complications to poorly maintained T1DM both in the short and 
long term.  The T1DM treatment regimen is designed to mimic the action of the pancreas 
through the injection of insulin to lower blood glucose levels from the consumption of 
carbohydrates.  Because of this imperfect science and the estimation that is involved in 
treatment, the body is subjected to abnormal concentrations of glucose and insulin, which 
puts a strain on many organs of the body.  For children and adolescents, whose brains are 
still developing, this constant fluctuation of blood glucose levels can cause damage to 
these developing structures and can cause cognitive impairment.  In addition to the 
constant aberration of blood glucose, individuals with T1DM also experience periods of 
extreme low blood glucose levels (hypoglycemia) and extreme high blood glucose levels 
(hyperglycemia), which have been associated with cognitive dysfunction, especially 
when it is experienced early in life (Desrocher & Rovet, 2004).  When compared with 
children and adolescents without a chronic illness, those with T1DM tend to perform 
worse on several measures of cognitive performance.  A meta-analysis examining studies 
that included youth with T1DM and healthy controls under the age of 18, revealed that 
children with T1DM performed moderately worse on measures of attention and executive 
functioning (Gaudieri et al., 2008).  There are several illness-related correlates and 
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demographic characteristics that have been proposed to explain the lower cognitive 
abilities seen in youth with T1DM which include frequency and severity of hypo- and 
hyperglycemia and age of T1DM onset (Sansbury, Brown, & Meacham, 1997).   
 Hypoglycemia is a condition in which blood glucose concentrations fall below 70 
mg/dl and individuals experience weakness, dizziness, and confusion and can lose 
consciousness.  It is fairly prevalent among children with T1DM, as there are many ways 
to become hypoglycemic including taking too much insulin or over-exercising (Beaser, 
2007).  There are several levels of hypoglycemia that can occur.  Asymptomatic and mild 
hypoglycemia can typically be treated by the individual simply by taking some type of 
sugar or fast acting carbohydrate.  Episodes of the most severe level of hypoglycemia 
result in a loss of consciousness and can lead to coma.  Each year, about 10% of children 
with T1DM experience the more severe type of hypoglycemia (Barkai, Vamosi, & 
Lukacs, 1998).   
There has been a significant amount of debate over the level and frequency of 
hypoglycemia that is needed to result in cognitive impairment.  Most research has found 
a significant association among episodes of hypoglycemia and impairments in several 
cognitive domains such as attention, executive functioning, and memory (Bjorgass, 
Gimse, Vik, & Sand, 1997; Rovet, Ehrlich, Czuchta, & Akler, 1993; Ryan et al., 1990).  
However, results from the Diabetes Control and Complications Trial Research Group 
(DCCT), which conducted a nine-year longitudinal study following 1441 adolescents and 
adults with T1DM, did not corroborate the finding that frequent hypoglycemia is related 
to cognitive impairment in youth with T1DM (DCCT, 1994; Musen et al., 2008).  These 
findings have been widely criticized due to the lack of a control group in the study, which 
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makes it difficult to draw conclusions about the effects of hypoglycemia on 
neuropsychological functioning over a period of time.  Additionally, there have been 
criticisms about some of the neuropsychological measures used in the DCCT.  
Specifically, most of the neuropsychological measures utilized in the study, other than the 
measure assessing intelligence, were not normed for individuals under the age of 16, 
which would likely lead to floor effects for the group of adolescents. Other reasons for 
this debate regarding the role of hypoglycemia in cognitive dysfunction may stem from 
how researchers measure hypoglycemic episodes.  There is tremendous variability in the 
severity of hypoglycemia that children experience.  For example, some children 
experience many episodes of the mildest form of hypoglycemia and are not aware that it 
is even occurring.  Other children experience nocturnal hypoglycemia, which also occurs 
outside of their awareness.  For children who are diagnosed with T1DM as infants, only 
the most severe levels of hypoglycemia can be treated since the milder levels rely on the 
individual’s report (Desrocher & Rovet, 2004).  Due to these reasons, it is difficult to 
study the effects of hypoglycemia on cognitive functioning.   
 Hyperglycemia is a condition in which individuals have severely high levels of 
blood glucose that can result from eating high carbohydrate food or not dosing the proper 
amount of insulin.  When individuals experience long durations of hyperglycemia, DKA 
can occur; this can lead to coma and eventually death if it is not treated (Beaser, 2007).  
There is evidence that people who experience DKA may suffer damage to their central 
nervous system and may experience deficits in their cognitive functioning.  It has been 
suggested that recurrent episodes of DKA may impact the myelin formation in specific 
areas of the developing brain.  For adolescents, whose brains are developing most rapidly 
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in the prefrontal cortex, this may affect their cognitive abilities, which typically show 
marked developments during this period (Rovet & Alverez, 1997).   
In general, research has found that acute episodes of hyperglycemia do not have 
the same deleterious effect on cognitive abilities in the way that episodes of 
hypoglycemia have been shown to have (Desrocher & Rovet, 2004).  One study 
examining the association between episodes of hyperglycemia and cognitive functioning 
demonstrated that children who had frequent episodes of hyperglycemia performed 
poorer on tasks of executive functioning than children who had not experienced as 
frequent episodes (Kaufman, Epport, Engilman, & Halvorson, 1999).  There is also some 
evidence that multiple episodes of DKA may be related to cognitive dysfunction as well 
(Lehmkuhl et al., 2009).  Perhaps these findings can be explained by the disruption in 
myelination of neurons in the developing frontal cortex from which the executive 
functions primarily stem.   
 One of the most consistent predictors of cognitive dysfunction among children 
and adolescents with T1DM is the age at which they were diagnosed.  Research has 
consistently demonstrated that early onset of diabetes (which typically means prior to age 
7) is associated with several domains of cognitive dysfunction.  Specific domains of 
cognitive functioning that have been shown to be most affected by early onset of the 
disease include motor speed, memory, and executive functioning (Ferguson, Blane, 
Wardlaw, Frier, Perros, McCrimmon et al., 2005; Rovet & Alvarez, 1997; Wolters, Yu, 
Hagen, & Kail, 1996).  Gaudieri and colleagues (2008) conducted a meta-analysis 
examining the cognitive deficits experienced by youth diagnosed with T1DM and found 
that they were at greater risk than healthy children to develop neurocognitive 
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complications.  This study went on to subdivide subjects into those that were diagnosed 
early in life and those who were not.  Results of these further analyses indicated that the 
cognitive deficits were even greater for those individuals who were diagnosed early in 
life (i.e. prior to age seven).   
It is difficult to determine the mechanisms through which early onset of the illness 
impacts the cognitive functioning of children.  Ryan (2006) hypothesized that the effects 
are merely a result of hypoglycemia that is not reported or treated due to the age of the 
children and their inability to acknowledge feelings of hypoglycemic episodes.  Prior to 
age seven the brain is undergoing changes in several areas.  According to Ryan’s (2006) 
diathesis hypothesis, these deficits seen in youth diagnosed at an early age are primarily 
due to chronic hyperglycemia that occurs during these critical periods of development, 
creating structural and functional changes to the CNS and leaving the brain vulnerable to 
later insults.  In studies examining cognitive dysfunction in children and adolescents with 
T1DM, the greatest deficits were seen in children who experienced a hyperglycemia-
induced seizure prior to age five (Rovet & Alvarez, 1997).  It is possible that a seizure 
experienced early in brain development increases the vulnerability to later brain insults 
from episodes of hypoglycemia, which has been found to be a consistent predictor of 
cognitive dysfunction. 
 Children and adolescents with T1DM appear to be at risk for deficits in several 
domains of their cognitive functioning which includes executive functioning (Gaudieri et 
al., 2008).  Research has demonstrated that our executive functioning abilities rely 
heavily on blood glucose as a source of energy, perhaps more than other cognitive 
functions (Gailliot & Baumeister, 2007).  Tasks that require our executive functions have 
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been shown to consume more glucose than tasks that utilize other cognitive abilities 
(Fairclough & Houston, 2004).  There have been many theories examining why executive 
dysfunction exists among individuals with T1DM, and some consistent correlates have 
emerged which include episodes of hypoglycemia, episodes of hyperglycemia and DKA, 
and age of disease onset.  Although these correlates are all different, to some degree all of 
these factors involve an increased vulnerability to the developing brain as a result of the 
unpredictability in blood glucose levels that are common to individuals with T1DM.  
Research has come a long way in examining the executive deficits that are found in this 
population; however, there has been little research exploring the potential behavioral 
consequences of these deficits.   
     Executive functioning and T1DM treatment adherence. 
 
 The development of decision-making skills and movement towards behavioral 
autonomy are important tasks of adolescence.  For adolescents with T1DM, these tasks 
have additional salience due to the additional challenges adolescents face as they begin to 
autonomously manage many of the tasks related to their T1DM diagnosis.  Given the 
deficits in executive functioning that children and adolescents appear to be more 
susceptible to, decision making competence may be directly related to the poor treatment 
adherence and metabolic control that is typically seen during adolescence.  Several 
research studies have examined decision making abilities among adolescents with T1DM 
and have found that poorer decision-making competence is significantly related to poorer 
treatment adherence and glycemic control (Miller & Drotar, 2007; Wysocki et al., 2008).  
These studies were cross-sectional designs and relied on self- and parent-report of 
decision making skills.  In another study, adolescents who participated in a six-week 
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problem solving diabetes education program displayed significantly better metabolic 
control (i.e., lower HbA1c values) and treatment adherence, as indicated by more frequent 
blood glucose checks, when compared to a control group six months following the 
intervention (Cook, Herold, Edinin, & Briars, 2002).  All of these studies that measured 
adolescents’ problem solving abilities provide further insight into the importance of 
executive function in managing a chronic illness such as T1DM.   
Although this research is important in informing researchers and clinicians about 
adolescent behavior, there has been little research examining the cognitive functions 
associated with decision-making among this population.  Specifically, executive 
functioning abilities, which have been shown to be moderately worse in adolescents with 
T1DM than they are in healthy adolescents, play a significant role in problem solving 
competency and should be explored in relation to treatment adherence and functional 
outcome measures such as metabolic control.   
Given the complexity of the diabetes treatment regimen, executive functions 
encompass many of the skills that are needed in order for individuals to successfully 
manage all of the self-care tasks that they are supposed to maintain.  To date, only a few 
studies have examined the relationship between executive functioning abilities in children 
and adolescents with T1DM and treatment adherence.  Bagner and colleagues (2007) 
examined this relationship in a sample of children and adolescents diagnosed with T1DM 
who were ages 8 to 19.  More developed executive functioning abilities, as measured by 
parents’ self report questionnaires, were related to better treatment adherence in youth of 
all ages.  This study provides some initial evidence that executive functions play an 
important role in the illness management of youth with T1DM; however, this study failed 
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to examine a measure of metabolic control.  Further, McNally, Rohan, Shroff Pendley, 
Delamater, & Drotar (2010) examined the associations among executive functioning, 
adherence, and metabolic control in a sample of children ages 9 to 11.  These researchers 
found that better executive functioning abilities were significantly related to better 
adherence.  Additionally, executive functioning served as a significant mediator in the 
relationship between treatment adherence and metabolic control.  Another research study 
with a sample of children (ages 9 to 11), using a longitudinal study design over two years 
found that changes in behavioral regulation predicted changes in adherence but not in 
glycemic control (Miller et al., 2012).  A limitation of these studies is that they 
exclusively used parent-report measures of youth’s executive functioning abilities but did 
not obtain a youth self-report or performance-based neuropsychological measures of 
executive functioning.   
Integration of Background Research 
 
 The adolescent years have been an area of focus in T1DM research due to a 
preponderance of evidence demonstrating that it is the period of development in which 
treatment adherence and metabolic control are the poorest (e.g. Anderson et al., 1990).  
To determine why this period of development is associated with these negative health 
outcomes, research has focused on several family variables including the amount of 
parental involvement (e.g. Helgeson et al., 2008), the amount of parental monitoring of 
T1DM management (e.g. Palmer et al., 2004), and the amount of conflict among parents 
and adolescents (e.g. Miller-Johnson et al., 1994).  All of these factors have been shown 
to be significant correlates of adolescent illness mismanagement; however, there appears 
to be a void in the literature with respect to another area of development that occurs 
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during adolescence.  Given the complexity involved in managing and planning for a 
flexible T1DM treatment regimen, advanced cognitive skills are likely necessary to 
successfully manage the illness.  Research examining cognitive development among 
healthy adolescents has indicated that this developmental process is usually not complete 
until the mid 20’s and, consequently, is partially responsible for the increased risk taking 
and lack of perspective taking that is common among adolescents (Giedd, 2004; 
Steinberg, 2005).  Adolescents with T1DM face these same biological challenges as 
healthy adolescents; however, they also experience further developmental complications 
as a result of their illness.  Adolescents with T1DM have been shown to experience 
deficits in several domains of cognitive functioning, including executive functioning 
abilities.  Although research has demonstrated that children and adolescents with T1DM 
display moderately worse executive functioning abilities when compared to healthy 
controls, there has been little research examining the behaviors or functional outcomes 
associated with these deficits (Gaudieri et al., 2008).   
 The current study focused on integrating these areas of research to further 
examine the multifaceted ways in which the family contributes to T1DM management 
among adolescents while accounting for their executive functioning abilities.   Upon 
careful review of the literature, there does not appear to be any research examining these 
family variables (i.e. parent involvement, parental monitoring, and family conflict) and 
cognitive variables (i.e. executive functions) to examine their aggregate contributions 
towards the prediction of treatment adherence and metabolic control.   
Further, these cognitive and family variables were incorporated into proposed 
moderation models which examined the ways through which executive functioning was 
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related to treatment adherence and metabolic control, while taking into account parental 
contributions to adolescents’ diabetes management.  It was hypothesized that the 
relationship between adolescents’ executive functioning and treatment adherence and 
metabolic control would be moderated by the amount of parental involvement or 
monitoring of adolescents’ T1DM management.  Specifically, it was expected that 
adolescents would be more likely to display poor adherence to their T1DM treatment 
regimen (and consequently worse metabolic control) when they are handed the 
responsibilities for autonomous management too early in their development when they do 
not possess the proper executive functioning abilities, especially in an environment in 
which they are not properly supervised.  Figure 1 depicts this proposed moderation 
model.    
The aims of the present study were as follows: 
I.  To examine whether adolescents’ executive functioning abilities were related to 
treatment adherence (i.e., replicating results of Bagner et al., 2007) and metabolic 
control. 
II. To examine the amount of variance that executive functioning accounted for in 
predicting adolescents’ treatment adherence and metabolic control beyond the 
contributions of family variables (i.e., parental involvement of T1DM 
management, parental monitoring of T1DM management, parent-adolescent 
conflict). 
III. To examine the role of parental monitoring and parental involvement in T1DM 
care in moderating the relationship between adolescents’ executive functioning and 
treatment adherence and metabolic control.   
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Figure 1.  Proposed model examining relationships among factors influential in 
adolescent    illness management 
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The hypotheses that were tested in the current study were as follows: 
Ia Adolescents’ executive functioning abilities (i.e., parent and adolescent reported 
BRIEF and adolescents’ D-KEFS scores and WCST scores) would be positively 
correlated with treatment adherence (i.e., SCI scores and total BG checks). 
Ib.     Adolescents’ executive functioning abilities (i.e., parent and adolescent reported  
BRIEF  and adolescents’ D-KEFS and WCST scores) would be negatively 
correlated with metabolic control (i.e., HbA1c values). 
IIa Adolescents’ executive functioning abilities (i.e., parent and adolescent reported 
BRIEF      and adolescents’ D-KEFS and WCST scores) would account for a 
significant percentage of variance in predicting adolescents’ treatment 
adherence (i.e., SCI scores) beyond the contributions of familial variables, 
including T1DM related conflict (i.e., DFCS total score) and the amount of 
parental involvement and parental monitoring of T1DM management (i.e., 
DFRQ and PMDC total scores). 
    IIb.  Adolescents’ executive functioning abilities (i.e., parent and adolescent reported  
BRIEF and adolescents’ D-KEFS and WCST scores) would account for a 
significant percentage of variance in predicting adolescents’ metabolic control 
(i.e., HbA1c) beyond the contributions of familial variables, including T1DM 
related conflict (i.e., DFCS total score) and the amount of parental involvement 
and parental monitoring of T1DM management (i.e., DFRQ and PMDC total 
scores). 
   IIIa.  The amount of parental involvement in adolescents’ T1DM management would 
moderate the relationship between adolescents’ executive functioning (i.e., 
34 
 
parent and adolescent reported BRIEF and adolescents’ D-KEFS and WCST 
scores) and treatment adherence (i.e., SCI scores). 
  IIIb.   The amount of parental monitoring of adolescents’ T1DM management would     
moderate the relationship between adolescents’ executive functioning (i.e., 
parent and adolescent reported BRIEF and adolescents’ D-KEFS and WCST 
scores) and treatment adherence (i.e., SCI scores). 
IIIc.  The combined contribution of parental involvement and monitoring (i.e.  
composite score of DFRQ and PMDC total scores) would moderate the 
relationship between adolescents’ executive functioning (i.e., parent and 
adolescent reported BRIEF and adolescents’ D-KEFS and WCST scores) and 
treatment adherence (i.e., SCI scores). 
  IIId.  The amount of parental involvement in adolescents’ T1DM management would 
moderate the relationship between adolescents’ executive functioning (i.e., parent 
and adolescent reported BRIEF and adolescents’ D-KEFS and WCST scores) and 
metabolic control (i.e., HbA1c). 
  IIIe.   The amount of parental monitoring of adolescents’ T1DM management would 
moderate the relationship between adolescents’ executive functioning (i.e., parent 
and adolescent reported BRIEF and adolescents’ D-KEFS and WCST scores) and 
metabolic control (i.e., HbA1c). 
 IIIf.    The combined contribution of parental involvement and monitoring (i.e.  
composite score of DFRQ and PMDC total scores) would moderate the 
relationship between adolescents’ executive functioning (i.e., parent and 
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adolescent reported BRIEF and adolescents’ D-KEFS and WCST scores) and 
metabolic control (i.e., HbA1c). 
Research Methods and Design 
 
Participants  
 
Eligible participants in the current study included adolescents, age 12 to 18, who 
had been diagnosed with T1DM at least six months prior to their participation in the 
study.  This length of diagnosis criterion is typical for studies examining children with 
T1DM and is thought to provide the adolescent and family a sufficient amount of time to 
adjust to the treatment demands the illness often requires.  For adolescents to be enrolled 
in the study, at least one of their parents had to agree to participate.  In order to 
participate in the present study, parents and adolescents had to be able to speak English, 
and adolescents could not be diagnosed with other chronic medical conditions requiring 
an additional treatment regimen.  Participants were recruited from the Children’s Hospital 
of Wisconsin (CHW) diabetes clinic.   
Procedures 
 
The recruitment of participants occurred through the following three methods: 
 One form of recruitment consisted of mailing letters explaining the study to eligible 
participants.  Potential participants were sent a postcard to return to the researchers 
indicating whether they were interested in participating in the study or not.   
 Another method of participant recruitment involved making phone calls to families 
who had previously agreed to be a part of the Registry Project (RP) in the diabetes clinic 
at CHW.  Psychologists at CHW developed the RP to make recruitment for behavioral 
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health research projects in the diabetes clinic more direct for families who were 
interested in taking part in research.  Families who had signed up for the project agreed 
to be directly contacted (by telephone or mail) to learn about studies taking place in the 
clinic for which they may be eligible.   
 Another method of recruitment involved speaking with families in the diabetes clinic 
at CHW when they arrived for their regularly scheduled appointment.  Interested 
families usually participated in the protocol following their appointment that day.   
 The three recruitment methods outlined above were conducted concurrently; 
however, attention was given to ensure that families were not contacted through multiple 
methods.  Following recruitment, most families who were interested in participating took 
part in the research project either prior to or following their regularly scheduled clinic 
appointment; however, some families scheduled a time to participate that was 
independent of their diabetes appointments.  If both parents attended the appointment, 
each parent completed the relevant questionnaires; however, it was more likely that one 
parent was present.  In these situations, a packet of study materials (i.e., consent forms 
and questionnaires) and a self-addressed, postage-paid envelope was sent home for the 
other parent to complete.  If these forms were not returned within two weeks of the clinic 
appointment, a follow-up phone call was placed to the family.   
 Parents and adolescents completed consent, assent, and Health Insurance 
Portability and Accountability Act (HIPAA) forms.  Following the consent procedure, 
parents and adolescents completed the questionnaires, as outlined in the subsequent 
section.  Once the adolescents completed the self-report measures, they were 
administered the performance-based, neuropsychological measures.   
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 Prior to their participation in the study, adolescents were asked to test their blood 
glucose values via finger prick testing using their personal meter.  If participants had 
readings that were below 75mg/dl, they were given a fast acting carbohydrate snack to 
bring their blood glucose levels into their target range (with an expected range for 
adolescents from about 90mg/dl to 150mg/dl; Bismuth & Laffel, 2007).  Following a 15-
minute break, participants were asked to recheck their blood glucose levels, and the study 
protocol resumed if their blood glucose value was above 90mg/dl.  This procedure was 
important because low blood sugars have been associated with sluggish cognitive tempo 
and research has demonstrated that executive functioning abilities are reliant on blood 
glucose (Beaser, 2007; Gailliot & Baumeister, 2007).     
 The current study took about one hour to complete, and each family was 
compensated with a $20.00 gift card to Target for their participation.  Approval was 
obtained from the Institutional Review Boards (IRB) at CHW and at Marquette 
University. 
Measures 
 
     Parent demographic questionnaire (Parent report) 
 
Parents completed a demographic questionnaire, which included basic 
demographic and illness-related information about the family and youth.  More 
specifically, it asked about parents’ personal information (e.g. occupation, education, 
annual income, ethnicity, marital status, custody arrangements of adolescent) as well as 
information about the adolescent with T1DM (e.g. length of T1DM diagnosis, number of 
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T1DM-related hospitalizations and clinic appointments, and additional medical 
diagnoses). 
     Self-Care Inventory-Revised version (SCI-R; Parent and Adolescent report) 
 
 The SCI-R is a self-report questionnaire that measures adherence to care 
behaviors that are associated with diabetes (La Greca & Bearman, 2003; Weinger, Butler, 
Welch, & La Greca, 2005).  It is comprised of 15 items that measure participants’ 
reported adherence of self or child in relation to a diabetes regimen over the previous two 
weeks.  The items measure various aspects of care including blood glucose monitoring, 
insulin injections, and maintenance of the prescribed diet and exercise recommendations 
of their physician.  Participants respond to each item on a five-point Likert scale that 
ranges from 1=complete nonadherence to 5= complete adherence.  The SCI-R was 
scored by calculating the mean of all the items and converting it to a 0 to 100-point scale.  
Higher scores on the SCI-R indicate a greater level of adherence (Weinger et al., 2005).   
 The SCI-R has been shown to be a reliable and valid measure of treatment 
adherence for children and adolescents with diabetes.  Adequate test-retest reliability has 
been demonstrated (Lewin et al., 2009).  There was evidence of good internal consistency 
in the current study for parents’ reports ( = .81) and for adolescents’ reports ( = .77).  
The SCI-R scores have been highly correlated with other measures of adherence, 
including a 24-hour recall interview and structured interview (Diabetes Self-management 
Profile; Greco et al., 1990; Harris et al., 2000; Lewin et al., 2009).  
     Diabetes Family Responsibility Questionnaire (DFRQ; Parent and Adolescent 
report) 
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 The DFRQ is a 17-item questionnaire that assesses how adolescents and their 
parents divide or share several tasks that are associated with adolescents’ diabetes care.  
There are three factors underlying the items in this measure that include responsibilities 
related to regimen tasks, general health maintenance, and social presentation of diabetes.  
For each item the participant is asked to indicate whether the (1) Parent(s) take 
responsibility for this task almost all of the time, (2) Parent(s) and child share 
responsibility for this task about equally, or (3) Child takes or initiates responsibility for 
this task almost all of the time (Anderson et al., 1990).  The DFRQ is scored by summing 
the items with higher scores representing a greater amount of autonomous management 
by the youth (Anderson et al., 1990) 
The current study found this measure to have acceptable internal consistency for 
parent ( = .84) and child ( = .78) report.  The DFRQ has also demonstrated acceptable 
levels of concurrent validity in prior research with the Independence Subscale on the 
Moos Family Environment scale (Moos, 1986; r = .21, p < .05) 
     Parental Monitoring of Diabetes Care Scale (PMDC; Parent and Adolescent 
report) 
 
 
The PMDC (Ellis et al., 2007) assesses how frequently parents monitor numerous 
aspects of their adolescents’ diabetes management regimen.  In separate parent and 
adolescent versions of the measure, respondents answer 18 questions and indicate how 
frequently parents monitored behavior during the past month.  Items are answered on a 
five-point Likert scale (e.g., “More than once a day,” “Once a day,” “Several times a 
week,” “Once a week,” and “Less than once a week”).  The five domains of monitoring 
measured by the PMDC include Availability of Medical Supplies/Devices, Monitoring of 
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Blood Glucose Checking, Oversight of Diet, Monitoring of Nonadherence, and Direct 
Oversight of Diabetes Management Behaviors.  The present analyses utilized a Total 
Monitoring Score, which is calculated by summing all items on the scale.  Scores can 
range from 18-90 with higher numbers representing higher levels of parental monitoring.   
In the present study there was evidence of adequate internal consistency for the 
total score with Cronbach’s alphas of .87 for the parent-report and .88 for the adolescent-
report versions.  Previous research has demonstrated that parental monitoring as assessed 
using the PMDC accounted for a significant amount of variance in predicting adolescent 
diabetes management and had a significant indirect effect on metabolic control (Ellis et 
al., 2007).  
     Diabetes Family Conflict Scale (DFCS; Parent and adolescent report)   
 
The DFCS (Hood, Butler, Anderson, & Laffel, 2007) is a parent- and youth-report 
questionnaire of the negative emotions that often surround several aspects of the diabetes 
treatment regimen.  The domains that are measured include blood-glucose monitoring, 
quality of life, and perceived parental burden from diabetes management.  Individuals are 
asked to respond on a three-point Likert scale (1= never argue, 2= sometimes argue, and 
3= always argue) indicating how much they have argued with their parent/adolescent 
about several diabetes-related tasks.  The measure is scored by summing all of the items, 
which yields a total conflict score ranging from 19 to 57, with higher numbers 
representing a greater amount of conflict (Hood et al., 2007).   
The DFCS was shown to have acceptable internal consistency in the present study 
for both parent ( = .87) and adolescent ( = .94) responses.  Previous research has also 
demonstrated excellent concurrent validity with measures of quality of life and negative 
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affect surrounding blood glucose monitoring (Hood et al., 2007).  In addition, the DFCS 
has demonstrated adequate predictive validity, as measured by significant correlations 
between family conflict scores and youths’ HbA1c values for child’s report and parent’s 
report of conflict (Hood et al., 2007). 
Measures of Cognitive Functioning  
 
     Behavior Rating Inventory of Executive Functioning (BRIEF; Parent report) 
 
 The BRIEF (Gioia, Isquith, Guy, & Kenworthy, 2000) is a parent-report measure 
of children’s and adolescents’ executive functioning.  The measure consists of 86 items 
that are designed to assess youths’ abilities to complete tasks which rely on several 
domains of executive functioning.  The measure consists of eight clinical scales and two 
validity scales.  These domains include abilities related to problem solving flexibility 
(Shift scale), anticipation of future events and setting goals (Plan/Organize scale), 
controlling impulses (Inhibit scale), modulation of emotional responses (Emotional 
Control scale), starting a task (Initiate scale), retaining information in one’s mind and 
following through to complete a task (Working Memory scale), keeping materials orderly 
(Organization of Materials scale), and assessing performance during or following a task 
(Monitor scale).  The individual scales have been organized into three indices which 
include the Behavior Regulation Index (BRI; Inhibit, Shift, and Emotional Control 
scales), the Metacognition Index (MI; Initiate, Working Memory, Plan/Organize, 
Organization of Materials, and Monitor scales), and the Global Executive Composite 
(GEC), which is derived from the two aforementioned indices and represents a total 
executive functioning score (Gioia et al., 2000).  All of the BRIEF subscale scores were 
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examined in bivariate analyses, and those correlations are presented in tables.  The 
BRIEF GEC was used in the multivariate analyses. Higher scores on the BRIEF represent 
greater levels of executive dysfunction.  
 The measure includes a list of statements that describes children’s behaviors, and 
parents are asked to indicate how frequently these behaviors are a problem for their child 
on a three-point Likert scale (Never, Sometimes, Often).  Research has demonstrated that 
the BRIEF is a reliable instrument with internal consistencies ranging from .80 - .98 
(Gioia et al., 2000).  The present study found the BRIEF Global Executive Composite 
score to have excellent internal consistency ( = .96).  Validity data has indicated that the 
measure provides consistent findings when compared with other ratings of children’s 
behavior, including the Child Behavior Checklist and Connors Rating Scale (Gioia et al., 
2000). 
Behavior Rating Inventory of Executive Functioning- Self-report version 
(BRIEF-SR, Adolescent report) 
 
 
 The BRIEF-SR (Guy, Isquith, & Gioia, 2004) is an adolescent-report measure of 
executive functioning for youth age 11 to 18.  The measure consists of 80 items that are 
designed to assess the youth’s abilities to complete tasks which rely on several domains 
of executive functioning.  The scales and indices for the BRIEF-SR are similar to those of 
the BRIEF.  The measure includes a list of statements that describes several behaviors, 
and adolescents are asked to indicate how frequently these behaviors are a problem on a 
three-point Likert scale (Never, Sometimes, Often).  Higher scores on this measure 
represent greater levels of executive dysfunction.  Research has demonstrated that the 
BRIEF-SR is a reliable instrument with internal consistencies ranging from .72 - .96 
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(Guy et al., 2004).  The present study found the BRIEF-SR GEC score to have excellent 
internal consistency ( = .94).  Validity data has indicated that the results of the BRIEF-
SR were moderately correlated with parent ratings from the BRIEF (Walker & D’Amato, 
2006).   
     Delis-Kaplan Executive Functioning System (D-KEFS; Adolescent report) 
 
 The D-KEFS (Delis, Kaplan, & Kramer, 2001a) is a well-validated 
neuropsychological assessment tool that is designed to measure various components of 
executive functions in children and adults.  The subtests of the D-KEFS include Trail 
making Test (TMT), Verbal Fluency Test (VFT), Design Fluency Test (DFT), Sorting 
Test (ST), Color-Word Interference Test (CWIT), Twenty Questions Test (TQT), Tower 
Test (TT), Word-Context Test (WCT), and the Proverb Test (PT).  The tests are 
presented to the participant in a game-like manner.  Each subtest gives a primary 
achievement score that is normed based on the individual’s age, yielding a scaled score 
with a mean of 10 and a standard deviation of 3 (Delis, et al., 2001a).  In the current 
study, the TT, VFT, and TMT were administered to participants. 
The TT is a similar task to an older executive functioning test, the Tower of 
London (Shallice, 1982).  The TT involves a wooden board with three pegs and five disks 
of varying sizes.  The participant is asked to move the discs, following a set of rules, from 
one peg to the next, to replicate the configuration displayed in a picture.  Fundamental 
abilities that are assessed by this task include several aspects of goal-directed behavior 
such as spatial planning, rule learning, self-guided action, inhibition of responses, and 
maintenance of an instructional set (Delis, et al., 2001a).   
44 
 
The VFT is very comparable to the Controlled Oral Word Association Test 
(COWAT; Benton, Hamsher, & Sivan, 1994) and is similarly comprised of two 
conditions, which include letter and category fluency tasks.  Participants are asked to 
state as many words that begin with a specified letter as they can in a 60-second interval.  
They are then given a category and are asked to state as many words that fall into that 
category as they can think of.  The task is scored by measuring the number of words 
generated, the number of incorrect responses, and the number of perseverative responses.  
Fundamental components of executive functioning that are measured with the VFT 
include cognitive flexibility and working memory (Delis, et al., 2001a).  
A final task from the D-KEFS battery that was administered to participants is the 
TMT.  The TMT is a classic executive functioning task that requires participants to draw 
lines from a variety of visual stimuli while following a meaningful pattern.  In one 
condition, individuals are asked to draw a line from one number to another in numerical 
order, and in another condition, they are asked to connect letters and numbers in 
alternating numeric and alphabetic order.  Achievement scores for this test are derived 
from the total completion time for each task.  The TMT measures visual scanning and 
attention as well as flexibility of thinking and working memory (Delis, et al., 2001a).   
 The reliability of all nine subtests has been shown to be satisfactory with internal 
consistencies ranging from .62 - .90 across all age groups.  The subtests have also been 
shown to be significantly correlated with several other well established tests of executive 
functioning, including the California Verbal Learning Test and the Wisconsin Card 
Sorting Task (Delis, Kaplan, & Kramer, 2001b).  Other research has demonstrated that 
the tests of the D-KEFS are sensitive to the deficits of executive functioning in 
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populations with frontal-lobe injury (Baldo, Shimamura, Delis, Kramer, & Kaplan, 
2001). 
     Wisconsin Card Sorting Task (WCST; Adolescent report)   
 
The WCST (Heaton, Chelune, Talley, Kay, & Curtiss, 1993) is a measure used to 
assess the ability to form abstract concepts, to shift and maintain set, and to utilize 
feedback.  It is designed for use with children and adults aged 5 to 89 years.  Participants 
are asked to sort a group of cards based on three criteria (i.e., color, form, and number) 
without any explicit directions.  Throughout the test, the sorting criterion changes, and 
participants are measured in their ability to fluidly modify their mental sets in accordance 
with the changing rules.  The test provides information on several aspects of problem 
solving behavior and includes indices such as number of perseverative errors, failure to 
maintain set, and the number of categories achieved.  The WCST has demonstrated 
excellent interscorer reliability with interclass correlations above .83 (Axelrod, Goldman, 
& Woodward, 1992), and it has also been shown to be a valid measure of executive 
functioning.  There is evidence that impairment on the WCST is associated with 
difficulties in real-world activities among children and adolescents with a traumatic brain 
injury (Levin et al., 1997) as well as difficulties with goal-directed behavior among youth 
diagnosed with attention deficit hyperactivity disorder (ADHD; Meyer et al., 2004). 
Rationale for Inclusion of Intelligence and Memory Measure  
 
  Intelligence and memory were assessed in the current study in addition to 
executive functioning to further explore whether any relationships that exist among 
adolescents’ cognitive functioning and the T1DM- or family-related variables were truly 
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due to their executive functioning and not their intelligence and/or memory functioning.  
Although intelligence, memory, and executive functioning are all cognitive functions, 
research has demonstrated that there is evidence of them being relatively distinct 
constructs.  Early research examining cognitive functioning provided evidence that 
individuals who underwent dorsolateral frontal lobectemies tended to display gross 
executive deficits, but they experienced relatively few deficits in Intelligence Quotient 
(IQ) scores (Milner, 1982).  Ardila and colleagues (2000) demonstrated that in a sample 
of 13 to 16 year-old adolescents, WISC-R scores were not correlated with most measures 
of executive functioning.  The only significant correlations that emerged were between 
Verbal Fluency scores and Verbal IQ and Full Scale IQ (FSIQ) scores.  From these 
studies it appears that intelligence tests are not sensitive to frontal lobe deficits which are 
better measured by tests of executive functioning.   
Research has also demonstrated an association between some aspects of memory 
and executive functioning.  A study examining the relationship between executive 
functioning abilities and measures of verbal and visual memory suggested that these 
constructs shared about 55% of variance.  Although this represents a significant amount 
of shared variance between the two constructs, this finding is not altogether surprising 
given the important role that working memory plays in mediating executive functioning 
abilities (Duff, Schoenberg, Scott, & Adams, 2005).  Given that there is some overlap 
between intelligence, memory, and EF abilities, participants in the present study were 
administered brief measures of their intellectual functioning and visual memory.  
Although the study hypotheses primarily examined EF abilities, these other cognitive 
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constructs were assessed to further explore the role that adolescents’ intelligence and 
memory may play in diabetes management.   
     Wechsler Abbreviated Intelligence Scale (WASI; Adolescent Report) 
 
 The WASI (Wechsler, 1999) is an abbreviated measure of intelligence that was 
created to be a quick and reliable screening instrument.  It is designed for use with 
children and adults aged 6 to 89 years.  The measure consists of four subtests which 
include Vocabulary, Similarities, Matrix Reasoning, and Block Design.  To administer 
the full battery, all four subtests are given; however, the abbreviated version consists of 
two subtests.  The two subtest abbreviated form of the WASI, which was administered in 
the present study, consists of the Vocabulary and Matrix Reasoning subtests.  To score 
the WASI, the total number of items correct for each subtest is converted to a T-score (M 
= 50; SD = 10) that is normed based on the individual’s age.  The two subtest T-scores 
are then summed and converted into a Full Scale Intelligence Quotient (FSIQ) score 
(Wechsler, 1999).   
The Vocabulary subtest consists of 42 items that require the individual to orally 
define a picture or word.  Items 1-4 are scored 0 or 1 points and consist of pictures that 
the individual must identify.  The remaining items are words that are presented to the 
participant both orally and visually.  These items are scored from zero to two points, and 
the individual must give a definition for each word.  Vocabulary provides a measure of 
individuals’ expressive vocabulary, verbal knowledge, and fund of information and also 
is thought to be a good measure of crystallized intelligence.  The Matrix Reasoning 
subtest is comprised of 35 items.  This subtest requires the individual to carefully 
examine a picture of an incomplete design and select one of five choices indicating which 
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piece completes the design.  Matrix Reasoning measures an individual’s nonverbal fluid 
reasoning and general intellectual ability (Wechsler, 1999).   
The WASI has demonstrated good reliability coefficients for each of the subtests 
among a sample of adolescents, including Vocabulary (.86 - .93) and Matrix Reasoning 
(.86 - .94) as well as for the FSIQ score for the abbreviated battery (.92 - .95), which 
suggests that the subtests and total scores are generally free from measurement error.  
Test-retest reliability among an adolescent sample has also been demonstrated to be 
acceptable for FSIQ scores (r  = .87).  The WASI has also been shown to be a valid 
measure of intelligence, as demonstrated by significant associations with scores on the 
Wechsler Intelligence Scale for Children (WISC-III; Wechsler, 1991; Wechsler, 1999).    
     Rey-Osterrieth Complex Figure (ROCF; Adolescent report) 
 
The ROCF (Meyers & Meyers, 1996) is a measure used to assess visual-spatial 
constructional ability and visual memory in individuals aged 6 to 93 years.  Participants 
are shown a picture of the complex figure, and they are asked to copy the picture on a 
blank sheet of paper.  Participants are then given 3-minute and 30-minute delayed recall 
tasks in which they are asked to recreate the picture on another sheet of paper without the 
stimulus card present.  During the delay intervals participants can complete other tasks as 
long as they are different than the ROCF and do not involve drawing.  The measures of 
performance on the ROCF were derived from copy and delay scores which reflect the 
accuracy of the original copy and provide an assessment of visual-constructional ability 
and memory.  In the present study, the ROCF was scored using the Meyers & Meyers 
(1996) scoring system.  Each participant’s responses were coded by two independent 
research assistants who met regularly to develop consensus scores for all conditions.     
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 The ROCF has been demonstrated to be a reliable measure with test-retest 
reliabilities of .76 for the immediate recall task and .89 for the 30-minute delayed recall 
over a 6-month period (Meyers & Meyers, 1995).  It also has been shown to be a valid 
measure of memory as demonstrated by significant associations with scores on the Token 
Test (Meyers & Meyers, 1995). 
Medical Record Data 
 
     Measure of metabolic control (HbA1c). 
 
    Metabolic control was indexed by obtaining the HbA1c values from the 
participants’ medical records from the most recent diabetes clinic visit.  The HbA1c was 
determined using the Bayer DCA 2000 instrument (Bayer Diagnostics Inc, Tarrytown, 
NY).  HbA1c reflects the average level of blood glucose control the individual has 
maintained over the previous 6-8 weeks.  Higher numbers reflect poorer control.  The 
average healthy individual has an HbA1c value of less than 6.5%, but this is usually 
higher in individuals with diabetes, who aim to maintain a value less than or equal to 
7.4% (American Diabetes Association, 2008).   
     Blood glucose monitoring data. 
 
 At each clinic appointment, families were asked to bring in adolescents’ blood 
glucose test results from the previous two weeks.   From this data we examined the 
frequency with which adolescents tested their blood glucose levels and calculated a mean 
number of checks per day value.  Research has demonstrated that the frequency of blood 
glucose tests is highly correlated with levels of metabolic control (Levine, Anderson, 
Butler, Brackett, & Laffel, 2001).  
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Results 
 
Data Analytic Plan 
 
The distributions of scores were assessed for skewness and kurtosis, and 
transformations were conducted as needed (Tabachnick & Fidell, 2007).  Due to 
significant skewness, DFRQ parent and youth involvement scores were transformed 
using square root transformations.  DFCS parent and youth reported diabetes conflict 
scores and the following BRIEF parent and BRIEF-SR youth reported scores were 
logarithmically transformed to approximate normal distributions: BRIEF and BRIEF-SR 
Planning/Organization and Behavioral Regulation Index scores and the Global Executive 
Composite score from the BRIEF-SR.  Additionally, the following variables from the D-
KEFS Trail Making Task were reflected and logarithmically transformed:  primary scores 
(amount of time) for the Visual Scanning, Number Sequencing, Letter Sequencing, 
Number/Letter Sequencing, and Motor Speed tasks.  The only other neuropsychological 
score that was transformed was the Failure to Maintain Set score on the WCST; this 
variable was also reflected and logarithmically transformed.  
The analyses of the first set of hypotheses exploring relationships among 
executive functioning, treatment adherence, and metabolic control variables were 
conducted using Spearman correlations.  The second set of hypotheses examining which 
variables were significant predictors of adolescent treatment adherence and metabolic 
control were conducted using hierarchical multiple regressions.   Analyses examining 
moderations were done using the method proposed by Baron and Kenney (1986) to 
determine if parental involvement and parental monitoring of T1DM management 
51 
 
moderated the relationship between adolescents’ executive functioning and treatment 
adherence and metabolic control.  Moderations were conducted examining parental 
involvement and parental monitoring separately as well as with an aggregate, “Overall 
Parental Contributions” variable.  This variable was created by converting the total scores 
from the DFRQ and PMDC to z-scores and then summing them into one combined score 
which reflects the amount of parental oversight and instrumental involvement they may 
provide in assisting adolescents with their diabetes care.   
Bivariate correlations involving variables from the BRIEF, BRIEF-SR, and the 
performance-based neuropsychological tests were examined using both raw test data and 
age-adjusted scaled scores or t-scores.  Examination of correlations with each of these 
types of data and the outcome variables yielded few differences in the strength or 
direction of these relationships.  This would suggest that there was sufficient variability 
among the age-adjusted scores, which would be expected given that the abilities being 
assessed in the study tend to develop across adolescence. Correlations with raw and age-
adjusted data are presented in tables throughout this manuscript; however, the age-
adjusted scaled or t-scores are described in text and were used in the multivariate 
analyses. 
Descriptive Analysis 
 
Analyses were based on the full sample of 84 participants, with the exception of 
adolescents’ blood glucose record data (n = 61).  The most common reason that families 
gave for this missing data was that they forgot to bring their log books to the study 
appointment or the adolescents indicated that they did not keep such records.  Parents and 
adolescents who attended the study protocol appointment completed the questionnaires 
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and/or neuropsychological measures, and participation took about 90 minutes.   If one 
parent was not present at the appointment, the family was asked to take a parallel set of 
consent forms and questionnaires to the other parent.  In total, 129 parents (81 mothers; 
48 fathers) completed the study protocol.  For the present analyses, data was used from 
the parent who self-identified and/or was identified by the other parent as the “Primary 
Diabetes Caregiver.”   
Descriptive statistics for the primary diabetes caregiver’s demographic 
characteristics are displayed in Table 1.  There was a wide variability in the ages of 
parents with a range of 31 to 74 years.  The sample of parents was predominately 
Caucasian (90.4%), well educated (i.e., 60% had at least a 4-year college degree), and 
relatively affluent (i.e., 48% reported earning at least $91,000).  As expected, and 
consistent with previous research, most of the parents identified as the primary diabetes 
caregiver were mothers (n = 77; 91.7%).  Seven fathers were identified as the primary 
diabetes caregivers (7.3%). 
Descriptive statistics for the adolescents’ demographic characteristics are 
displayed in Table 2.  The sample of adolescents consisted of slightly more males than 
females (45 males; 39 females) with a mean age of 14.27 years (SD = 1.78; range = 12-
18).  The majority of adolescents participating in the study were Caucasian (86.9%).  
There was sufficient variability among HbA1c values (M = 8.39; SD = 1.67) with a range 
in values of 5.8% to 14%, with higher values representing poorer metabolic control.  
Adolescents’ mean length of diagnosis was 5.95 years (SD = 3.67), and 69% of 
participants dosed and administered their insulin via syringes or insulin pens, rather than 
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Table 1. Primary Diabetes Caregiver Demographic Characteristics 
 
 
 Mean SD Range 
 
n % 
Age (years) 
Sex 
          Female 
          Male 
Ethnicity 
          Caucasian 
          African American 
          Latino/Hispanic 
          Other 
Family Income  
          Less than $30,000 
          $31,000 - $60,000 
          $61,000 – $90,000 
          $91,000 - $120,000 
          $121,000 - $150,000 
          Greater than $150,000 
Education 
          High School Education 
          Trade School/2-year College Degree 
          ≥ 4-year College Degree 
45.94 6.67 
 
 
 
 
31 - 74 
 
 
 
 
 
 
77 
 7 
 
75 
6 
1 
1 
 
9 
14 
19 
20 
7 
12 
 
11 
23 
50 
 
 
91.7 
7.3 
 
90.4 
7.2 
1.2 
1.2 
 
11.1 
17.3 
23.5 
24.7 
8.6 
14.8 
 
13 
27.4 
59.6 
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Table 2. Adolescent Demographic Characteristics 
 
 
 
 
 Mean SD Range 
 
% 
Age (years) 
Sex 
          Female 
          Male 
Ethnicity 
          Caucasian 
          African American 
          Latino/Hispanic 
          Asian American 
          Biracial 
          Other 
Diabetes Related Information 
          Length of Diabetes Diagnosis (years) 
          Age of Diagnosis (years)        
          Most recent metabolic control (HbA1c) value 
          Average number of blood glucose checks/day  
          Adolescents who receive insulin via pump 
14.27 
 
 
 
 
 
 
 
 
 
 
 
5.95 
8.36 
8.39 
4.94 
1.78 
 
 
 
 
 
 
 
 
 
 
 
 
3.87 
3.99 
1.67 
2.19 
12-18 
 
 
 
 
 
 
 
 
 
 
 
.67 – 15.75 
1.10 – 17.00 
5.80 – 14.00 
1.93 – 11.86 
 
 
 
46.4 
53.6 
 
86.9 
4.8 
2.4 
1.2 
2.4 
1.2 
 
 
 
 
 
30.9 
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with insulin pumps.  Given the strong relationship between attentional capacity and 
executive functions (Barkley & Murphy, 2011), parents were asked on the demographics 
form to note whether their adolescent participating in the study had a preexisting 
diagnosis of ADHD.  In total, eight youth (9.5%) were identified as having a diagnosis of 
ADHD.   
Prior to participation in the study, adolescents were asked to check their blood 
glucose values via finger prick testing using their personal meter to ensure that they were 
within the expected range (90mg/dl to 150mg/dl; Bismuth & Laffel, 2007).  Adolescents 
had mean blood glucose values of 162.86 mg/dl (SD = 87.20), and about half of 
participating adolescents (48%) had blood glucose readings that were outside of the 
normative range; these participants made dietary adjustments or administered insulin and 
retested themselves to ensure that their blood glucose was in the expected range (follow-
up blood glucose tests: M = 146.38 mg/dl; SD = 31.08).   
The descriptive data for the questionnaires are presented in Table 3 and 
neuropsychological data are presented in Tables 4 and 5.       
 Preliminary Analysis 
 
 Preliminary analyses were conducted using parametric (t-test and ANOVA) and 
nonparametric (Mann-Whitney U Test) statistical analyses to explore potential 
relationships among the demographic and diabetes-related variables (i.e., age, sex, 
race/ethnicity, income, length of time with T1DM, type of insulin administration) and the 
study variables to identify potential covariates.  There were five general demographic 
covariates (i.e., adolescent age, sex, ethnicity, family income, and diagnosis of ADHD)  
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Table 3.  Means, Standard Deviations, and Ranges For Self-Report Measures 
 
Variable Mean SD Range 
Parental Involvement (DFRQ) 
          Parent  
          Adolescent 
Parental Monitoring (PMDC) 
          Parent  
          Adolescent 
 
35.15 
37.63 
 
62.22 
66.42 
 
5.03 
4.78 
 
13.98 
13.26 
 
23 - 49 
25 - 47 
 
37 - 89 
36 - 89 
Diabetes-Related Conflict (DFCS) 
          Parent 
          Adolescent 
 
24.74 
26.22 
 
5.47 
8.31 
 
18 - 49 
19 - 52 
Treatment Adherence (SCI-R) 
         Parent  
         Adolescent  
BRIEF (Parent report; T-scores)     
         Metacognition Index Score 
         Behavioral Regulation Index 
         Global Executive Composite 
BRIEF-SR (Adolescent report; T-scores) 
        Metacognition Index Score 
        Behavioral Regulation Index 
        Global Executive Composite 
 
70.74 
75.28 
 
52.78 
49.98 
51.63 
 
47.44           
46.94 
47.01 
 
13.31 
12.32 
 
10.43 
9.49 
9.83 
 
10.26 
10.29 
10.51 
 
40 – 96.67 
40 – 100 
 
36 – 82 
36 – 77 
35 – 82 
 
21 – 78 
26 – 82 
23 - 83 
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Table 4.  Means, Standard Deviations, and Ranges for Subtests from the D-KEFS 
 
 
 
 
 
 
 
 
 
 
 
Variable Mean SD Range 
Wisconsin Card Sorting Task     
          Total Items Administered (raw score) 
          Categories Completed (raw score) 
          Failure to Maintain Set (raw score) 
99.96 
5.39 
.74 
21.09 
1.29 
1.06 
70 – 128 
0 – 6 
0 – 5 
          Perseverative Errors (T-score) 
          Non-Perseverative Errors (T-score) 
Rey-Osterrieth Complex Figure  
          Copy score (T-score) 
          Delay score (T-score) 
54.25 
53.94 
 
29.83 
39.67 
11.87 
10.80 
 
11.09 
12.64 
28 – 80 
25 – 73 
 
17 – 61.5 
19 – 68  
Wechsler Abbreviated Scale of Intelligence    
          Full Scale IQ (FSIQ; standard score) 99.17 11.76 55 – 130  
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Table 5.  Means, Standard Deviations, and Ranges for Neuropsychological Measures of 
Executive Functioning, Intelligence, and Memory 
 
 
 
 
 
 
Variable Mean SD Range 
D-KEFS Trail Making Task (scaled scores)    
          Visual Scanning 11.32 2.30 1 - 15 
          Number Sequencing 9.90 3.05 1 - 14 
          Letter Sequencing 10.57 2.40 1 – 15 
          Number-Letter Sequencing 9.36 3.14 1 – 14 
          Motor Speed 9.15 3.44 1 -14 
D-KEFS Verbal Fluency Task (scaled scores)    
          Letter Fluency Total Score 9.48 3.02 1 - 16 
          Category Fluency Total Score 10.07 3.38 1 - 19 
          Category Switching Total Score  10.25 3.48 2 - 19 
          Percent Set Loss Errors 11.63 2.04 1 - 13 
          Percent Repetition Errors 10.05 3.23 1 -13  
D-KEFS Tower Task (scaled scores)    
          Total Achievement 9.92 2.15 1 - 15 
          Move accuracy 9.24 2.71 1 - 15 
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and two diabetes-related covariates (i.e., length of diagnosis and type of insulin 
administration) that emerged from this analysis.   
      General demographic covariates. 
 
Adolescent age was significantly related to the number of blood glucose checks, r 
= -.39, p < .01, and youth-reported treatment adherence, r = -.25, p < .05.  Further, both 
parents, r = -.28, p < .05, and adolescents, r = -.56, p < .01, reported lower levels of 
parental monitoring of diabetes care for older adolescents.  Examination of a measure of 
parental involvement in diabetes care revealed similar results with both parents, r = .61, p 
< .01, and adolescents, r = .66, p < .01, indicating greater autonomy of care for older 
adolescents.   On neuropsychological measures, adolescent age was significantly related 
to the D-KEFS Trail Making Test Visual Scanning, r = .27, p < .05, and Tower Task 
Move Accuracy, r = .35, p < .05, scores.   
There were significant differences between boys and girls for parents’ reports of 
their involvement in adolescents’ diabetes care, t(82) = -2.56; p < .05, with parents noting 
greater autonomy of care for girls compared to boys.  Similar to the findings for 
adolescent age, there were also significant differences based on adolescent’s sex for the 
D-KEFS Trail Making Test Visual Scanning, t(82) = -2.08; p < .05, and Tower Task 
Move Accuracy, t(82) = -2.11; p < .05, scores, which indicated that girls had better 
developed executive functions than boys in the areas assessed by these measures.  
Due to the racially homogenous nature of the sample, we dichotomized the data 
(i.e. Caucasian vs. Non-Caucasian) for the purposes of analyses to examine possible 
differences in variables of interest by racial/ethnic groups.  T-test analyses were 
conducted and revealed significant differences for parent-reported involvement in 
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adolescents’ diabetes care, t(81) = 3.01; p < .01, with parents of Caucasian youth 
reporting more adolescent autonomy for their diabetes care than for non-Caucasian 
adolescents.  There were also differences between these groups for two of the subtests 
from the D-KEFS Trail Making Test.  Specifically, Number Sequencing, t(81) = 2.24; p 
< .05, and Motor Speed, t(81) = 2.00; p < .05, abilities significantly differed, such that 
Caucasian adolescents demonstrated more developed executive abilities as assessed by 
those measures compared to adolescents of an ethnic minority background.   
Parent-reported diabetes-related conflict experienced with adolescents 
significantly differed based on family income, F(2,78) = 4.27, p < .05.  Post hoc analyses 
indicated that families who earned less than $60,000/year reported significantly more 
conflict than families earning more than $121,000/year.  Adolescents’ metabolic control, 
as measured by their most recent HbA1c values, also differed significantly among families 
based on family income.  Specifically, post hoc analyses revealed differences among 
those families in the highest earnings bracket (>$121,000/year; mean HbA1c = 8.02%; SD 
= 1.04) and those families with the lowest annual incomes (<$60,000/year; mean HbA1c 
= 9.12%; SD = 1.85).  More affluent families had adolescents who maintained 
significantly better metabolic control compared to families with the lowest income in this 
study.   
Due to the discrepancy in diagnostic group sizes, Mann-Whitney U tests were 
performed to compare the ranks for the n = 8 adolescents with a diagnosis of ADHD and 
the n = 76 adolescents without a diagnosis of ADHD.  Parent and youth report of 
adolescents’ executive functioning abilities differed significantly based on adolescents’ 
diagnostic history of ADHD.  According to parent-reported Global Executive Composite 
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scores on the BRIEF, parents reported significantly poorer executive functioning skills 
for youth with a preexisting diagnosis of ADHD (mean rank = 70.63) as compared to 
youth without such a diagnosis (mean rank = 39.54), Z = -3.43; p < .01.  Likewise, this 
same difference was found when examining adolescents’ reports of their own executive 
functioning on the BRIEF-SR, such that adolescents with a diagnosis of ADHD (mean 
rank = 60.00) endorsed poorer executive functioning compared to adolescents without a 
diagnosis of ADHD (mean rank = 40.66), Z = -2.14; p < .05. 
Examination of neuropsychological tests of executive functioning demonstrated 
one significant difference in performance based on diagnostic history of ADHD.  
Performance on the Wisconsin Card Sorting Task (Total Administration), Z = -2.66; p < 
.01, revealed poorer executive functioning for adolescents who had a diagnosis of ADHD 
(mean rank = 64.19) compared to those adolescent without such a diagnosis (mean rank = 
40.22).   
      Diabetes-related demographic covariates. 
 
 Results revealed significant differences in several areas of adolescents’ 
functioning based on their method of insulin administration.  Adolescents who 
administered their insulin with syringes or pens endorsed significantly more T1DM-
related conflict with their parents than those who were on an insulin pump, t(79) = 2.46; p 
< .01.  Additionally, adolescents who were on an insulin pump were in better metabolic 
control, as evidenced by lower HbA1c values, t(79) = 2.39; p < .01, and also tested and 
logged their blood glucose levels more frequently, t(57) = -3.77; p < .05, than adolescents 
who used syringes or pens to dose and administer their insulin.    
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Analyses also revealed significant differences in adolescents’ executive 
functioning based on the method of insulin administration.  On a parent report measure of 
adolescents’ executive functioning (BRIEF), parents indicated that adolescents who 
administer their insulin with syringes or pens have greater problems with behavioral 
inhibition (Inhibit subscale) than those who are on an insulin pump, t(79) = 2.46; p < .05.  
Adolescents who use syringes or pens to administer their insulin reported more problems 
with behavioral inhibition, t(79) = 2.03; p < .05, and endorsed greater difficulty 
completing a task (BRIEF-SR Task Completion subscale), t(79) = 2.07; p < .05, as 
compared to adolescents who were on an insulin pump.  Performance on a 
neuropsychological measure assessing several aspects of goal-directed behavior such as 
spatial planning, self-guided action, and maintenance of an instructional set (i.e., D-KEFS 
Tower Task Total Achievement Score) also differed based on adolescents’ method of 
insulin administration.  Adolescents who used syringes or pens displayed significantly 
lower scores on this measure as compared to youth who were on a pump, t(79) = -2.12; p 
< .05.  The aforementioned findings examining the differences among those youth who 
receive their insulin via syringe/pen vs. a pump are not altogether surprising given the 
philosophy of the CHW diabetes clinic regarding which families are eligible for a pump.  
In this clinic, which tends to be somewhat conservative with pump distribution, families 
who are interested in receiving a pump have to demonstrate a generally high level of 
successful management over a period of time using syringes/pens before a pump will be 
prescribed.  
Correlations among self-report and neuropsychological measures of 
executive functioning 
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In order to gain a comprehensive assessment of adolescents’ executive 
functioning abilities, the present study utilized self and parent report measures in addition 
to performance-based neuropsychological measures of the construct.  We examined 
correlations among index scores from the parent-reported BRIEF, adolescent-reported 
BRIEF-SR, and neuropsychological measures of executive functioning to determine the 
extent to which these measures were assessing similar aspects of executive functioning.  
These correlations are presented in Tables 6 and 7.  In general, there were very few 
statistically significant correlations between these two methods of executive functioning 
assessment.    
Examination of Participants in the Early Onset Diagnosis Group  
 
 Based on previous research findings that suggest poorer neurocognitive 
functioning among youth who were diagnosed with T1DM prior to age seven (early onset 
diagnosis group) compared to youth who were diagnosed later in life, t-test analyses were 
conducted to examine differences in participants’ performance on measures of 
neuropsychological functioning, self- and parent-report measures of executive 
functioning, and measures of illness management by age of T1DM onset.  Of the total 
sample, 28 adolescents (33.3%) were in the early onset diagnosis group.  Analyses 
revealed no statistically significant differences based on age of diagnosis for the BRIEF 
or BRIEF-SR scores.  The only significant difference on self-report measures of illness 
management was on the adolescent-reported DFRQ which measures responsibility 
sharing for diabetes care.  Adolescents in the early onset group reported having more 
responsibility for the independent management of their T1DM care compared to 
adolescents who were diagnosed later in life, t(82) = -2.28; p < .05.  There were no  
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Table 6.  Correlations Among BRIEF and BRIEF-SR Index Scores and D-KEFS 
Subscales 
* p< .05.   
 
 
Variable BRIEF 
BRI 
BRIEF 
MCI 
BRIEF 
GEC 
BRIEF-
SR BRI 
BRIEF-
SR MCI 
BRIEF-
SR GEC 
D-KEFS Trail Making        
      Visual Scanning -.13 -.20 -.21 -.06 -.10 -.09 
      Number Sequencing -.05 -.15 -.15 -.07 -.20 -.13 
      Letter Sequencing .06 .01 .02 -.20 -.25* -.25* 
      Number-Letter 
Sequencing 
-.12 -.07 -.13 -.15 -.10 -.13 
      Motor Speed -.12 .06 -.01 -.27* -.08 -.17 
D-KEFS Verbal Fluency        
      Letter Fluency Total  .09 .05 .07 .06 .02 .07 
      Category Fluency 
Total  
-.01 .04 .04 -.10 -.10 -.11 
      Category Switching 
Total  
.03 .01 .03 -.01 -.08 -.03 
      Percent Set Loss  -.06 .03 .01 -.09 .07 .01 
      Percent Repetition        .06 .20 .13 .21 .14 .17 
D-KEFS Tower Task        
      Total Achievement -.12 -.05 -.08 -.11 .02 -.03 
      Move accuracy -.06 .01 -.03 -.14 -.04 -.06 
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Table 7. Correlations Among BRIEF and BRIEF-SR Index Scores and 
Neuropsychological Measures of Executive Functioning, Intelligence, and Memory 
* p< .05.   
 
 
 
 
 
 
 
 
 
Variable BRIEF 
BRI 
BRIEF 
MCI 
BRIEF 
GEC 
BRIEF-
SR BRI 
BRIEF-
SR MCI 
BRIEF-
SR GEC 
Wisconsin Card Sorting Task        
     Total Items Administered (raw) .13 .18 .17 .02 .09 .04 
     Categories Completed (raw) -.21 -.21 -.21 -.01 -.06 -.02 
     Failure to Maintain Set (raw) -.04 -.03 -.06 -.04 -.01 -.03 
     Perseverative Errors  -.12 -.16 -.15 -.01 -.09 -.03 
     Non-Perseverative Errors -.16 -.21 -.22* -.06 -.08 -.06 
Rey-Osterrieth Complex Figure       
     Copy Score -.02 -.09 -.01 -.23* -.14 -.18 
     Delay Score -.15 -.11 -.11 -.16 -.13 -.15 
WASI       
     Full Scale IQ (FSIQ) -.02 -.06 -.02 -.05 -.04 -.03 
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significant differences between these two groups for any of the performance-based 
measures of neuropsychological functioning. 
 Consistent with previous research, which generally has found an association 
between treatment adherence and metabolic control, parents’, r = -.23, p < .05, and 
youth’s, r = -.37, p < .01, reports of adolescent’s treatment adherence were significantly 
related to most recent HbA1c values.  Data collected from participants’ blood glucose 
records (i.e., average number of blood glucose checks per day), which provided a proxy 
measure of treatment adherence, was also significantly related to adolescents’ metabolic 
control, r = -.25, p < .05.  There was a moderate level of agreement between parent and 
adolescent reports of adolescent treatment adherence as measured by the SCI-R, r = .57, 
p < .01.   
Hypotheses Ia and Ib: Associations Among Adolescents’ Executive Functioning, 
Treatment Adherence, and Metabolic Control 
 
 
 To examine the first set of hypotheses, bivariate correlations were examined 
among adolescents’ executive functioning variables, treatment adherence (as measured 
by parent and adolescent report and by average daily blood glucose checks), and 
metabolic control (as measured by participants’ most recent HbA1c values).   
Associations among parent- and adolescent-reported BRIEF scores, 
adolescent treatment adherence, and metabolic control. 
 
 
Bivariate associations among executive functioning variables, as measured by 
parent-reported BRIEF, and adolescent’ treatment adherence and metabolic control are 
presented in Table 8a and 8b.  Higher scores on the BRIEF represent greater levels of 
executive dysfunction.  Several subscales on the parent-reported BRIEF were  
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Table 8a.  Correlations Among Parent-Reported BRIEF Subscales (T-Scores), Measures 
of Adolescent Treatment Adherence, and Metabolic Control 
* p< .05.  **p< .01 
 
 
 
 
 
 
 
Variable SCI-R 
Parent 
SCI-R 
Youth 
Blood Glucose 
Checks 
HbA1c 
BRIEF (Parent Report) 
          Inhibit 
          Shift 
          Emotional Control 
          Initiate 
          Working Memory 
          Planning/Organization 
 
-.39** 
       -.10 
       -.18 
-.39** 
-.41** 
-.36** 
 
-.11 
.        .08 
-.08 
-.18 
-.16 
-.15 
 
-.20 
          .02 
-.09 
-.09 
-.24 
-.23 
 
.18 
-.03 
.09 
.18 
.16 
       .29** 
          Organization 
          Monitoring 
          Behavioral Regulation Index 
-.36** 
-.34** 
      -.26* 
       -.24* 
         .01 
-.06 
-.24 
-.22 
-.11 
.11 
.05 
.11 
         Metacognition Index 
         Global Executive Composite 
-.39** 
-.41** 
-.17 
-.13 
-.23 
-.20 
.20 
.16 
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Table 8b.  Correlations Among Parent-Reported BRIEF Subscales (Raw Data), Measures 
of Adolescent Treatment Adherence, and Metabolic Control  
* p< .05.  **p< .01 
 
 
 
 
 
 
 
Variable SCI-R 
Parent 
SCI-R 
Youth 
Blood Glucose 
Checks 
HbA1c 
BRIEF (Parent Report) 
          Inhibit 
          Shift 
          Emotional Control 
          Initiate 
          Working Memory 
          Planning/Organization 
 
-.31** 
-.06 
-.13 
-.35** 
-.34** 
-.31** 
 
-.01 
.15 
.01 
-.07 
-.02 
-.01 
 
-.28* 
-.14 
-.18 
-.21 
-.28* 
-.30* 
 
.09 
-.10 
.03 
.09 
.11 
.20 
          Organization 
          Monitoring 
          Behavioral Regulation Index 
-.30** 
-.30** 
       -.20 
-.10 
.10 
.01 
-.28* 
-.30* 
-.16 
.05 
.02 
.07 
         Metacognition Index 
         Global Executive Composite 
-.41** 
-.35** 
-.16 
-.12 
-.18 
-.09 
  .22* 
.17 
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significantly associated with parents’ reports of adolescents’ treatment adherence (SCI-
R).  Specifically, the Global Executive Composite, which is an aggregate score reflecting 
adolescent’s overall executive abilities, was significantly inversely associated with 
adolescents’ treatment adherence, r = -.41, p < .01.   There was a significant association 
between the BRIEF Organization subscale score and adolescents’ reports of their own 
treatment adherence, r = -.24, p < .05.  There were no significant correlations among 
parent-reported BRIEF T-scores and adolescents’ average number of blood glucose 
checks.    
 Bivariate associations among executive functioning variables, as measured by the 
adolescent-reported BRIEF-SR, and adolescents’ treatment adherence and metabolic 
control are presented in Tables 9a and 9b.  There were several significant associations 
between subscales on the BRIEF-SR and adolescents’ report of their own treatment 
adherence (SCI-R) and an objective measure of adherence (i.e., average number of blood 
glucose checks).  The Global Executive Composite score was significantly related with 
adolescent-reported treatment adherence, r = -.40, p < .01, and with the average number 
of blood glucose checks, r = -.30, p < .05.  Examination of data across reporters revealed 
several significant associations among BRIEF-SR subscales and parents’ reports of 
adolescents’ executive functioning.  Specifically, the Planning/Organization scale, r = -
.26, p < .05, Organization scale, r = -.23, p < .05, Task Completion scale, r = -.24, p < 
.05, and the Metacognition Index, r = -.23, p < .05, scores were significantly related to 
parent reported SCI-R scores.  These results suggest that adolescents who displayed 
behaviors consistent with better developed executive functions tended to be more 
adherent to their diabetes treatment regimen.   
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Table 9a.  Correlations Among Adolescent-Reported BRIEF-SR Subscales (T-scores), 
Measures of Adolescent Treatment Adherence, and Metabolic Control 
* p< .05.  **p< .01 
 
 
 
 
 
 
 
Variable SCI-R 
Parent 
SCI-R 
Youth 
Average BG 
Checks 
HbA1c 
BRIEF-SR (Adolescent Report) 
          Inhibit 
          Shift 
          Emotional Control 
          Monitoring 
          Working Memory 
          Planning/Organization 
 
-.11 
-.05 
-.02 
-.12 
-.11 
-.26* 
 
-.33** 
-.28* 
-.29** 
-.21 
-.28* 
-.41** 
 
-.27* 
-.30* 
      -.23 
 -.34** 
-.28* 
      -.28* 
 
.21 
.12 
.06 
.18 
.05 
      .24* 
          Organization 
          Task Completion 
          Behavioral Regulation Index 
-.23* 
-.24* 
-.05 
-.29** 
-.29** 
-.32** 
       -.04 
-.19 
-.30* 
.16 
      .33** 
.14 
         Metacognition Index 
         Global Executive Composite 
-.23* 
-.19 
-.36** 
-.40** 
-.27* 
-.30* 
.19 
.18 
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Table 9b.  Correlations Among Adolescent-Reported BRIEF-SR Subscales (Raw Data),  
Measures of Adolescent Treatment Adherence, and Metabolic Control 
* p< .05.  **p< .01 
 
 
 
 
 
 
 
Variable SCI-R 
Parent 
SCI-R 
Youth 
Average BG 
Checks 
HbA1c 
BRIEF-SR (Adolescent Report) 
          Inhibit 
          Shift 
          Emotional Control 
          Monitoring 
          Working Memory 
          Planning/Organization 
 
-.13 
-.06 
-.01 
-.13 
-.11 
 -.27* 
 
 -.33** 
-.24* 
 -.31** 
-.23* 
 -.29** 
 -.41** 
 
-.24 
  -.27* 
-.21 
    -.33** 
       -.26* 
-.24 
 
.22* 
.16 
.11 
.22* 
.10 
  .28* 
          Organization 
          Task Completion 
          Behavioral Regulation Index 
 -.24* 
 -.26* 
-.07 
 -.30** 
 -.32** 
 -.35** 
-.01 
-.20 
   -.31* 
  .22* 
    .39** 
.16 
         Metacognition Index 
         Global Executive Composite 
 -.25* 
-.20 
 -.37** 
       -.39** 
-.23 
  -.29* 
  .22* 
.20 
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There were not many significant associations among BRIEF subscale T-scores 
and adolescents’ HbA1c values; however, the Planning/Organization subscale score was 
significantly associated with adolescents’ HbA1c values, r = .29, p < .01, such that 
adolescents who had more developed planning and organizational abilities displayed 
better metabolic control.  Similarly, there were not many significant relationships 
between BRIEF-SR scales and adolescent’s HbA1c values, although the 
Planning/Organization, r = .24, p < .05, and Task Completion, r = .33, p < .01, subscales 
were significantly related to HbA1c values, suggesting that adolescents who had more 
developed executive skills related to planning, organization, and completion of tasks 
displayed better metabolic control. 
Associations among performance-based measures of adolescents’ 
neurocognitive functioning, treatment adherence, and metabolic control. 
 
 
 The current analyses also explored bivariate associations among performance-
based neuropsychological measures of adolescents’ executive functioning, treatment 
adherence, and metabolic control.  These correlations are presented in Tables 10a, 10b, 
and 11.  Analyses revealed few statistically significant relationships among these 
constructs.  Parent report of adolescents’ treatment adherence was significantly related to 
the percent of repetition errors on the D-KEFS Verbal Fluency task, r = -.22, p < .05, and 
Non-Perseverative Errors on the Wisconsin Card Sorting Task (WCST), r = .27, p < .05.  
The average number of daily blood glucose checks was significantly correlated with the 
Number Sequencing task from the D-KEFS, r = -.25, p < .05, which suggests that 
adolescents who were more efficient in their sequencing abilities tended to have fewer  
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Table 10a.  Correlations Among D-KEFS Subscales (Scaled Scores) with Measures of 
Adolescent Treatment Adherence, and Metabolic Control 
* p< .05.  
 
 
 
 
 
Variable SCI-R 
Parent 
SCI-R 
Youth 
Average BG 
Checks 
HbA1c 
D-KEFS Trail Making Task (scaled scores)     
          Visual Scanning .05 -.13 -.18 -.05 
          Number Sequencing .05 -.07 -.25*  .01 
          Letter Sequencing -.11 -.16 -.15 -.11 
          Number-Letter Sequencing .06 -.08 -.07  .03 
          Motor Speed -.03 -.03 .04 -.05 
D-KEFS Verbal Fluency Task (scaled scores)     
          Letter Fluency Total Score  -.10 -.06 -.06 -.06 
          Category Fluency Total Score   -.17 -.12 -.06  .01 
          Category Switching Total Score          .05  .14 .02 -.02 
          Percent Set Loss Errors  -.10  .01 -.11  .05 
          Percent Repetition Errors   -.22* -.21 -.10  .03 
D-KEFS Tower Task (scaled scores)     
          Total Achievement -.05 -.11 .06  .01 
          Move accuracy -.17 -.13 -.01 .08 
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Table 10b.  Correlations Among D-KEFS Subscales (Raw Data) with Measures of 
Adolescent Treatment Adherence and Metabolic Control 
** p< .01. 
 
 
 
 
 
Variable SCI-R 
Parent 
SCI-R 
Youth 
Average 
BG Checks 
HbA1c 
D-KEFS Trail Making Task (scaled scores)     
          Visual Scanning .02 .18 .21 -.05 
          Number Sequencing -.01 .11     .36** -.03 
          Letter Sequencing .11 .18 .25  .09 
          Number-Letter Sequencing -.03 .17 .21 -.09 
          Motor Speed .05 .04 .04  .01 
D-KEFS Verbal Fluency Task (scaled scores)     
          Letter Fluency Total Score -.20 -.16 -.15 .04 
          Category Fluency Total Score -.20 -.16 -.15 .04 
          Category Switching Total Score  .01 .09 -.04 .10 
          Percent Set Loss Errors .09 .01 .13 -.05 
          Percent Repetition Errors .15 .10 .01 -.04 
D-KEFS Tower Task (scaled scores)     
          Total Achievement -.07 -.16 .01 .01 
          Move accuracy .17 .12 .01 -.07 
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Table 11.  Correlations Among Neuropsychological Measures of Executive Functioning, 
Intelligence, and Memory with Measures of Adolescent Treatment Adherence and 
Metabolic Control 
* p< .05.  
 
 
 
 
 
 
 
 
Variable SCI-R 
Parent 
SCI-R 
Youth 
Average 
BG Checks 
HbA1c 
Wisconsin Card Sorting Task      
          Total Items Administered (raw score) 
          Categories Completed (raw score) 
          Failure to Maintain Set (raw score) 
-.18 
.14 
-.05 
-.05 
.01 
-.08 
-.13 
.20 
-.11 
.15 
-.07 
.11 
          Perseverative Errors (T-score) 
          Non-Perseverative Errors (T-score) 
Rey-Osterrieth Complex Figure  
          Copy score (T-score) 
          Delay score (T-score) 
.09 
.27* 
 
-.13 
-.01 
.01 
.08 
 
-.17 
-.12 
.09 
.13 
 
-.12 
-.11 
-.15 
-.12 
 
.04 
-.05 
Wechsler Abbreviated Scale of Intelligence     
          Full Scale IQ (FSIQ; standard score) .05 -.02 .08 -.23* 
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blood daily blood glucose checks.  There were no meaningful associations among any of 
the neuropsychological measures of executive functioning and adolescents’ reports of 
treatment adherence (SCI-R) or HbA1c values, which is a finding that is consistent with 
what was found in the DCCT (DCCT, 1994). 
 In addition to exploring the relationships among neuropsychological measures of 
executive functioning with treatment adherence and metabolic control, we also examined 
these relationships with brief measures of adolescents’ memory (i.e., Rey-Osterrieth 
Compex Figure) and intelligence (i.e., WASI; see Table 11).  The only statistically 
significant relationship that emerged among these measures of neuropsychological 
functioning and illness management was between adolescents’ Full Scale IQ (FSIQ) and 
HbA1c values, r = -.23, p < .05, such that adolescents with more developed intellectual 
abilities displayed better metabolic control. 
Hypotheses IIa and IIb:  Relative Contributions of Illness Management, Family 
Functioning, and Executive Functioning Variables in the Prediction of Adolescents’ 
Treatment Adherence  
 
 
To test the second set of hypotheses, a series of hierarchical multiple regressions 
were conducted.  The first hierarchical multiple regression examined the contributions of 
parental involvement and monitoring, diabetes-related conflict, and parent reports of 
adolescent’s executive functioning in the prediction of parent-reported adolescent 
treatment adherence.  Results from the regression are presented in Table 12 and represent 
the contributions at each step of the regression and the final regression model.  The 
demographic variables that were significantly related to the predictor variables (i.e., 
adolescent age, family income, adolescent sex, adolescent diagnosis of ADHD) were 
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Table 12.  Multiple Regression Effects for Parent-Reported Family Functioning Variables 
and Executive Functioning Predicting Parent-Reported Adolescent Treatment Adherence 
Step Unstandardized 
β 
Standard 
Error 
Standardized 
β 
R
2
 ∆R2 
1. Adolescent age 
Family income 
Adolescent sex 
ADHD diagnostic status 
2. Parent involvement 
Parental monitoring 
3. T1DM-related conflict 
Final Model: 
4. Adolescent age  
Family income 
Adolescent’s sex 
ADHD diagnostic status 
Parent involvement 
Parental monitoring 
T1DM-related conflict 
Global Executive  
Composite (BRIEF) 
-1.87 
1.71 
4.08 
-1.98 
.85 
.32 
-.67 
 
-1.71 
.59 
1.22 
-8.14 
.45 
.28 
-.48 
 
-.42 
.84 
.95 
2.96 
5.06 
.35 
.10 
.27 
 
.95 
.90 
2.64 
4.77 
.35 
.10 
.27 
 
.15 
 -.25* 
.20 
.15 
-.04 
 .32* 
   .33** 
 -.28* 
 
-.23 
.07 
.05 
-.18 
.17 
  .30** 
-.20 
 
  -.31** 
 
 
 
.11 
 
.25 
.31 
 
 
 
 
 
 
 
 
 
.37 
 
 
 
   .11 
 
  .14** 
.06* 
 
 
 
 
 
 
 
 
   
.06** 
* p< .05.  **p< .01 
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entered into the regression first, measures of parent-reported involvement in and 
monitoring of T1DM care were entered second, parents’ reports of the diabetes-related 
conflict was entered third, and parents’ report of adolescents’ executive functioning (i.e. 
Global Executive Composite score from the BRIEF) was entered fourth.  Although it was 
initially proposed that the regression models would include adolescents’ intellectual 
functioning and memory to examine the relative contributions of these neurocognitive 
variables in addition to executive functioning, these variables were not included in 
analyses due to the lack of significant relationships with the variables of interest at a 
bivariate level.   
The results of the regression indicated that the overall model was significant, 
F(8,80) = 5.38, p < .01, and predicted about 37% of the variance in parent-reported 
adolescent treatment adherence.  The demographic variables, R
2
 change = .11, F(4,80) = 
2.23, p = .07, did not account for a significant percentage of variance in the prediction of 
adolescents’ treatment adherence.  In the second step, parental involvement and 
monitoring contributed a significant amount of unique variance in predicting treatment 
adherence, R
2
 change = .14, F(6,80) = 4.06, p < .01, as did parent-adolescent conflict, 
which was entered in the third step of the regression, R
2
 change = .06, F(7,80) = 4.71, p < 
.01.  Parent-reported adolescent executive functioning was entered in the final step of the 
regression.  This variable added a significant amount of unique variance in predicting 
adolescent treatment adherence after taking into account the related demographic 
variables, illness management, and family functioning variables, R
2
 change = .06, F(8,80) 
= 5.38, p < .01.  In the final model, parental monitoring of diabetes management and 
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adolescent’s executive functioning were the only significant predictors of adolescent 
treatment adherence. 
A second hierarchical multiple regression was conducted to examine the 
contributions of parental monitoring, diabetes-related conflict, and adolescents’ reports of 
their executive functioning in the prediction of adolescent-reported treatment adherence.  
Results from the regression are presented in Table 13 and represent the contributions at 
each step of the regression and the final regression model.  The demographic variables 
that were significantly related to the predictor variables (i.e., adolescent age, parent 
ethnicity, adolescent ADHD diagnostic status, method of insulin administration) were 
entered into the regression, a measure of adolescent-reported parental monitoring of 
T1DM care was entered second, adolescent report of diabetes-related conflict was entered 
third, and adolescents’ report of adolescents’ executive functioning (i.e. Global Executive 
Composite score from the BRIEF-SR) was entered fourth.  
The results of the regression indicated that the overall regression model was 
significant, F(7,79) = 6.02, p < .01, and predicted about 37% of the variance in 
adolescents’ treatment adherence.  The demographic variables, R2 change = .13, F(4,79) 
= 2.84, p < .05, predicted a significant percentage of variance in treatment adherence.  In 
the second step, parental monitoring of adolescents’ diabetes management contributed a 
significant amount of unique variance in predicting treatment adherence as well, R
2
 
change = .06, F(5,79) = 3.52, p< .05.  Similar to the results from the previous regression 
examining parent-reported measures, adolescent-reported diabetes-related conflict also 
contributed a unique amount of variance in predicting treatment adherence, R
2
 change = 
.13, F(6,79) = 5.84, p< .01.  In the final step, adolescent-reported executive functioning  
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Table 13.  Multiple Regression Effects for Adolescent-Reported Family Functioning 
Variables and Executive Functioning Predicting Adolescent-Reported Treatment 
Adherence 
Step Unstandardized 
β 
Standard 
Error 
Standardized 
β 
R
2
 ∆R2 
1. Adolescent age 
Parent’s ethnicity 
ADHD diagnostic status 
Insulin administration type 
2. Parental monitoring 
3. T1DM-related conflict 
Final Model: 
4. Adolescent age  
Parent’s ethnicity 
ADHD diagnostic status 
Insulin administration type 
Parental monitoring 
T1DM-related conflict 
Global Executive 
Composite (BRIEF-SR)  
-2.27 
-2.64 
-4.57 
1.17 
.28 
-40.97 
 
-1.68 
-.95 
-7.92 
-1.23 
.22 
-34.45 
 
-.28 
.78 
1.86 
4.65 
3.03 
.12 
10.84 
 
.84 
1.66 
4.23 
2.72 
.11 
10.94 
 
.12 
-.33** 
-.16 
-.11 
.04 
.30* 
-.38** 
 
-.24 
-.06 
-.19 
-.05 
 .24* 
  -.32** 
 
  -.24* 
 
 
 
.13 
.19 
.32 
 
 
 
 
 
 
 
 
.37 
 
 
 
.13* 
.06* 
.13** 
 
 
 
 
 
 
 
 
.05* 
* p< .05.  **p< .01 
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also contributed a unique amount of variance in predicting adolescents’ treatment 
adherence after taking into account the related demographic variables, illness 
management, and family functioning variables, R
2
 change = .05, F(7,79) = 6.02, p< .05.  
Examination of the final model revealed that parental monitoring of diabetes care, 
diabetes-related conflict, and adolescent executive functioning were the only significant 
predictors of treatment adherence.  
A third hierarchical regression was conducted to examine the prediction of 
adolescents’ metabolic control, as measured by their most recent HbA1c values.   Results 
from the regression are presented in Table 14 and represent the contributions at each step 
of the regression and the final regression model.  In this regression model, the 
demographic variables that were significantly related to the predictor variables (i.e., 
adolescent age, length of T1DM diagnosis, family income) were entered first and 
accounted for about 15% of the variance in predicting adolescents’ HbA1c values, R 
2
= 
.15, F(3,77) = 4.58, p < .01.  A measure of adolescents’ intellectual functioning (FSIQ) 
was included in the second step of the model due to its significant relationship with 
adolescents’ metabolic control at the bivariate level.  After taking into account the related 
demographic variables, adolescent IQ did not account for a significant percentage of 
unique variance in predicting HbA1c values.  Similarly, adolescent-reported parental 
monitoring of diabetes care also was not a significant predictor of metabolic control in 
the third step.  In the fourth step of the model, parent-adolescent diabetes-related conflict 
did account for a significant percentage of unique variance in predicting HbA1c values [R
2
 
change = .08; p < .01].  The Planning and Organization subscale score from the BRIEF-
SR was added in the final step of the regression because it was the only subscale from the  
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Table 14.  Multiple Regression Effects for Intelligence, Adolescent-Reported Parental 
Monitoring, Parent-Reported Diabetes Related Conflict, and Adolescent-Reported 
Executive Functioning Predicting Adolescents’ HbA1c values  
Step Unstandardized 
β 
Standard 
Error 
Standardized 
β 
R
2
 ∆R2 
1. Adolescent age 
Length of diagnosis 
Family income 
2. Full Scale IQ (FSIQ) 
3. Parental monitoring 
4. T1DM-related conflict 
Final Model 
5. Adolescent age  
Length of diagnosis 
Family income 
Full Scale IQ (FSIQ) 
Parental monitoring 
T1DM-related conflict 
Planning and organization 
(BRIEF-SR) 
.89 
.01 
-.01 
-.01 
.00 
.26 
 
.00 
.00 
-.00 
.00 
.00 
.22 
 
.15 
.01 
.00 
.01 
.00 
.00 
.09 
 
.01 
.00 
.01 
.00 
.00 
.10 
 
.10 
 .09 
 .18 
 -.28* 
-.16 
-.13 
    .30** 
 
 .02 
  .22* 
-.14 
-.14 
-.11 
  .25* 
 
.17 
 
 
.15 
.18 
.19 
.27 
 
 
 
 
 
 
 
 
.29 
 
 
 .15** 
.03 
.01 
 .08** 
 
 
 
 
 
 
 
 
.02 
* p< .05.  **p< .01. 
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BRIEF-SR that was significantly associated with metabolic control at the bivariate level; 
this measure of executive functioning did not contribute a significant amount of unique 
variance to the model.  The overall model was significant and accounted for about 29% 
of the variance in predicting adolescent’s HbA1c values, F(7,73) = 4.23, p < .01. 
Examination of the final model revealed that length of T1DM diagnosis and diabetes-
related conflict were the only significant predictors of metabolic control.  
Hypotheses IIIa, IIIb, IIIc, IIId, IIIe, and IIIf:  Moderation of Executive 
Functioning and Treatment Adherence by Parental Involvement and Monitoring 
 
 
 Moderation analyses were used to determine if variables assessing parental 
contributions to adolescents’ diabetes care (e.g. parental monitoring, parental 
involvement) served as moderators to the relationships between adolescents’ executive 
functioning abilities and treatment adherence.  Several moderations were examined to 
assess parent- and adolescent-reported measures of the aforementioned constructs.  
Although initially proposed, we did not examine moderation models involving the 
prediction of adolescents’ HbA1c values due to a lack of significant associations among 
the constructs of interest at the bivariate level.   
All of the moderation analyses were conducted using hierarchical multiple 
regressions.  First, the independent variables and the moderators were “centered” to 
reduce the effects of multicollinearity (Aiken & West, 1991).  Centering these variables 
involved subtracting the sample means from each of the scores.  The related demographic 
variables were entered into the first step of the regressions followed by the main effects 
of the moderators and predictors, and the interaction of the moderators and predictors 
were entered into the final step of the regressions.  Baron and Kenney (1986) guidelines 
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were used, which state that statistical moderation is met if there is a significant 
interaction between the moderator and the independent variable, after the effects of the 
moderator and independent variable are controlled for.   
     Moderation of parent-reported adolescent executive functioning and 
treatment adherence by parent-reported involvement and monitoring of diabetes 
care. 
 
 The first set of moderation analyses examined the prediction of parent-reported 
adolescent treatment adherence.  Results depicting the final models of these regressions 
are presented in Table 15.  The regression equation testing the hypothesis that parental 
involvement would moderate the relationship between adolescent’s executive functioning 
and treatment adherence was found to be statistically significant and explained about 
23% of the variance in predicting adolescent’s treatment adherence, F(4,83) = 5.96, p < 
.001.   
 In the first step, adolescent sex was entered (male =1; female = 2), as it was 
significantly related to parent reports of their involvement in diabetes care.  Parent reports 
of adolescent executive functioning (BRIEF Global Executive Composite; BRIEF GEC) 
was entered second and contributed a significant amount of unique variance, R
2
 change = 
.16, F(2,83) = 8.03, p < .01, in predicting adolescent treatment adherence; adolescent 
executive functioning was a significant predictor of adherence in the final model as well, 
β = -.41, t(83) = -4.03, p < .001.  In the third step, parent-reported parental involvement 
in diabetes care (DFRQ Parent) was entered, but this variable did not predict a significant 
amount of unique variance in adolescents’ treatment adherence, R2 change = .01, F(3,83) 
= 5.31, p > .05.  In the final step of the regression analysis, an interaction term between  
 
85 
 
Table 15. Summary of Regression Analyses Testing Moderation Models Predicting 
Parent-Reported Adolescent Treatment Adherence 
 
* p< .05.  **p< .01. 
 
 
 
 
 
 
 
 
 
Moderation Predictor Variable F R
2
 p β 
Model #1 Adolescent sex 5.96 .23 < .001 -.01 
 BRIEF GEC      -.41** 
 DFRQ parent     .04 
 BRIEF x DFRQ    -.26* 
Model #2 Adolescent age 6.72 .25 < .001 -.09 
 BRIEF GEC      -.36** 
 PMDC parent      .26* 
 BRIEF x PMDC    -.03 
Model #3 Adolescent age 5.28 .21 < .01 -.11 
 BRIEF GEC      -.40** 
 Parental contributions (Parent-report)    .09 
 BRIEF x Parental contributions    .12 
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adolescents’ executive functioning and parental involvement was created, which 
accounted for a significant proportion of the variance in treatment adherence, R
2
 change = 
.07, p <.05, β = -.26, t(83) = -2.60, p < .05.  These results suggest that parental 
involvement does serve as a significant moderator to the relationship of adolescents’ 
executive functioning and treatment adherence.  Specifically, adolescents with better 
executive functioning abilities were more adherent to their treatment regimen, especially 
when parents were less involved in adolescents’ diabetes management.  This interaction 
model is displayed in Figure 2.   
 A second moderation model was conducted to determine whether parental 
monitoring served as a moderator to the relationship between adolescent executive 
functioning and treatment adherence.  Adolescent age was entered in the first step, and it 
contributed a significant amount of variance in predicting treatment adherence, R
2 
= .05, 
F(1,83) = 4.10, p < .05.  The main effects of parent-reported adolescent executive 
functioning and parental monitoring were entered in the second and third steps, 
respectively, and each was found to contribute a significant amount of variance in 
predicting adherence.  Adolescents’ executive functioning, β = -.36, t(83) = -3.67, p < 
.001,  and parental monitoring, β = .26, t(83) = 2.54, p < .05, variables were both found to 
be significant predictors in the final model.  In the final step of the regression analysis, an 
interaction term between adolescents’ executive functioning and parental monitoring was 
created, which did not account for a significant proportion of the variance in treatment 
adherence, R
2
 change = .01, p > .05, β = -.03, t(83) = -.31, p > .05. 
 A third moderation model examining the prediction of parent-reported adolescent 
treatment adherence was conducted examining parental contributions to adolescents’  
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Figure 2. Parent-Reported Involvement in Adolescents’ Diabetes Care Moderates the 
Relationship Between Adolescents’ Executive Functioning and Treatment Adherence 
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diabetes care.  An aggregate variable was created, combining parents’ reports of their 
involvement and monitoring behaviors in order to capture their overall contributions in 
assisting in adolescents’ diabetes management.  In this model, adolescent age was entered 
in the first step, as it was a significant demographic covariate.  This demographic variable 
contributed a significant amount of variance in predicting adolescent treatment 
adherence, as did parents’ reports of adolescents’ executive functioning, which was 
entered in the second step, R
2 
change = .14, F(2,83) = 9.56, p < .001.  The aggregate 
score assessing parental contributions to diabetes care (Parental Contributions) was 
entered in the third step of the regression and did not contribute a significant amount of 
variance in predicting treatment adherence.  Similarly, when an interaction term between 
adolescents’ executive functioning and parental contributions was entered in the fourth 
step of the regression model, this variable was not a significant predictor, R
2
 change = 
.01, p > .05, β = .12, t(83) = 1.19, p > .05. 
Moderation of adolescent-reported executive functioning and treatment 
adherence by adolescent-reported parental involvement and monitoring of diabetes 
care. 
 
 
 The second set of moderation analyses examined the prediction of adolescent-
reported treatment adherence.  Results depicting the final models of these regressions are 
presented in Table 16.  The first regression equation tested the hypothesis that adolescent-
reported parental involvement would moderate the relationship between adolescents’ 
executive functioning and treatment adherence.  The overall model was found to be 
statistically significant and explained about 26% of the variance in predicting 
adolescent’s treatment adherence, F(4,83) = 6.96, p < .001.  In the first step, adolescent  
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Table 16. Summary of Regression Analyses Testing Moderation Models Predicting 
Adolescent-Reported Treatment Adherence 
 
a
 p = .07.  * p< .05.  **p< .01. 
 
 
 
 
 
 
 
 
Moderation Predictor Variable F R
2
 p β 
Model  #1 Adolescent age 6.96 .26 < .001  -.47** 
 BRIEF-SR GEC      -.33** 
 DFRQ adolescent     .25 
 BRIEF-SR x DFRQ    -.19
a
 
Model #2  Adolescent age 6.66 .25 < .001 -.16 
 BRIEF-SR_GEC      -.28** 
 PMDC adolescent     .29* 
 BRIEF-SR x PMDC    -.01 
Model #3 Adolescent age 1.40 .07 > .05 .08 
 BRIEF-SR_GEC    .19 
 Parental contributions (Youth-report)    -.06 
 BRIEF-SR x Parental contributions    .09 
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age was entered, as it was significantly related to adolescent report of treatment 
adherence.  Adolescent reports of executive functioning (BRIEF-SR Global Executive 
Composite; BRIEF-SR GEC) was entered second and contributed a significant amount of 
unique variance, R
2
 change = .10, F(2,83) = 9.83, p < .01, in predicting adolescents’ 
treatment adherence; adolescents’ executive functioning was a significant predictor of 
adherence in the final model as well, β = -.33, t(83) = -3.13, p < . 01.  In the third step, 
adolescent-reported parental involvement in diabetes care (DFRQ Adolescent) was 
entered; this variable did not predict a significant amount of unique variance in 
adolescents’ treatment adherence, R2 change = .03, F(3,83) = 7.90, p = .07.  In the final 
step of the regression analysis, an interaction term between adolescents’ executive 
functioning and parental involvement was created, and this variable approached statistical 
significance, R
2
 change = .03, p = .07, β = -.19, t(83) = -1.85, p = .07.  These results 
suggest that parental involvement may serve as a significant moderator to the relationship 
of adolescents’ executive functioning and treatment adherence; although this relationship 
was only at a trend level.  Specifically, adolescents with better executive functioning 
abilities were somewhat more adherent to their treatment regimen, especially when 
parents were less involved in adolescents’ diabetes management.  This interaction model 
is displayed in Figure 3.   
 A regression equation was tested to examine the hypothesis that adolescent-
reported parental monitoring would moderate the relationship between adolescent-
reported executive functioning and treatment adherence.  Adolescent age was entered in 
the first step, and it contributed a significant amount of variance in predicting treatment 
adherence, R
2 
= .09, F(1,83) = 8.42, p < .01.  The main effect of adolescent-reported  
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Figure 3. Adolescent-Reported Involvement in Adolescents’ Diabetes Care Moderates the 
Relationship Between Adolescents’ Executive Functioning and Treatment Adherence 
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executive functioning was entered in the second step, and it too contributed a significant 
amount of unique variance in predicting adherence, R
2
 change = .10, F(2,83) = 9.83, p < 
.01.  In the third step of the regression, parental monitoring (PMDC Adolescent) was 
entered, and it was also a significant predictor of adolescents’ treatment adherence, R2 
change = .06, F(3,83) = 8.98, p < .05.  In the final step of the regression analysis, an 
interaction term between adolescents’ executive functioning and parental monitoring was 
created, which did not account for a significant proportion of the variance in treatment 
adherence, R
2
 change = .00, p > .05, β = -.01, t(83) = -.14, p > .05. 
 The final moderation model that was conducted examined the hypothesis that 
parental contributions to adolescents’ diabetes care would moderate the relationship 
between adolescent-reported executive functioning and treatment adherence.  The 
“parental contributions” variable was a composite variable created from combining the 
adolescent-reported parental monitoring and involvement scores.  In the first step of the 
regression, adolescent age was entered, adolescent-reported executive functioning was 
entered second, parental contributions to adolescents’ diabetes management was entered 
third, and an interaction term combining executing functioning and parental contributions 
was entered fourth.  The overall regression model predicted 6% of variance in 
adolescent’s treatment adherence and was not significant, F(4,83) = 1.40, p = .24.  In the 
final model, none of the main effects or interaction variable were significant predictors of 
adherence.    
Discussion 
 
 This study sought to further examine the relationships among adolescents’ 
executive functioning abilities, parental involvement in diabetes care, and treatment 
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adherence and metabolic control among adolescents with type 1 diabetes mellitus.  In 
general, results supported our hypotheses, in that adolescents with better developed 
parent and self-reported executive functions tended to display better adherence to their 
T1DM treatment regimen.  Additionally, parent and self-reports of adolescent executive 
functioning were shown to be significant predictors of adherence beyond the 
contributions of several demographic and family functioning variables.  Examination of 
parents’ contributions to adolescents’ T1DM management revealed that parental 
involvement was a significant moderator of the relationship between adolescents’ 
executive functioning and treatment adherence, such that parental involvement had a 
larger impact for adolescents who demonstrated poorer executive functions.   
Relationship Between Adolescents’ Executive Functioning and Illness Management 
 
The first hypothesis explored the associations between adolescents’ executive 
functioning and treatment adherence and metabolic control.  Executive functioning was 
assessed with parent- and adolescent-report measures as well as with performance-based 
neuropsychological measures.  Results exploring relationships between a parent-report 
measure of adolescents’ executive functioning and treatment adherence were consistent 
with previous research, which demonstrated a significant relationship between parent-
reported BRIEF scores and parent-report of adolescent treatment adherence.   
Similar results were obtained when examining the relationship of adolescent-
reported executive functioning (BRIEF-SR) scores and adolescents’ reports of their own 
adherence.  Additionally, adolescent reports of executive functioning were also 
significantly related to parent-reported (SCI-R) and objective (frequency of blood glucose 
checks) measures of adherence, such that better developed executive functioning was 
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significantly associated with better adherence and more frequent blood glucose checks.  
To our knowledge, this study is the first to demonstrate the relationship between 
adolescent-reported executive functioning and treatment adherence, as previous studies 
examining this association have typically utilized parent-report measures of adolescent 
executive functioning (Bagner et al., 2007; McNally et al., 2010).  Given the complexities 
of managing an often changing and multi-step T1DM treatment regimen, this study offers 
additional evidence that executive functions may play a significant role in aiding 
adolescents in their self-management.  Despite the robust correlations that were observed 
between parent- and self-reported executive functions and adherence, there were few 
significant associations found among neuropsychological measures of executive 
functioning and either measure of adherence (i.e., questionnaire or blood glucose check 
frequency).  The lack of significant associations with the performance-based, 
neuropsychological measures is addressed later in the discussion. 
A secondary aim of the first hypothesis was to examine relationships among 
adolescents’ executive functioning and metabolic control, as assessed by recent HbA1c 
values.  Results from the current study suggested that there were few significant 
associations among parent and adolescent reports of overall executive functioning and 
adolescents’ HbA1c values.  However, parent and adolescent reports of adolescents’ 
planning and organizational abilities and adolescent reports of task completion were 
significantly correlated with HbA1c.  The Planning/Organize subscales on the BRIEF and 
BRIEF-SR assess adolescents’ abilities to manage current and future-oriented task 
demands by assessing their capacity to anticipate future events, develop a goal, and 
determine the most effective and efficient way to reach that goal (Gioia et al., 2000).  
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Similarly, the Task Completion subscale on the BRIEF-SR assesses adolescents’ abilities 
to develop an organized plan and to complete a multi-step task appropriately and 
efficiently (Guy et al., 2004).  These results suggest that of the multifaceted domains that 
are involved in executive functioning, adolescents’ abilities related to holding a goal in 
mind, developing a plan to achieve that goal, while inhibiting task-irrelevant actions may 
be particularly important skills for adolescents to manage their illness demands to 
maintain acceptable levels of metabolic control.  Successful diabetes management 
requires youth to adjust their insulin dosage based on the results of blood glucose 
monitoring, assessment of the number of carbohydrates consumed, and amount of 
activity they have taken part in or will plan to do in the near future.  For adolescents who 
have poorly developed executive functions, these tasks may be more difficult to 
successfully coordinate and execute.  
Examination of the performance-based measures of executive functioning 
assessed in the current study revealed no significant correlations with adolescents’ 
metabolic control; however, assessment of a measure of intelligence found that youth 
with higher FSIQ scores tended to have better metabolic control.  The measure of 
intelligence was included in multivariate analyses involving the prediction of 
adolescents’ HbA1c values, and it was found to not be a significant predictor of metabolic 
control once several demographic characteristics (e.g., adolescent age, length of 
diagnosis, family income) were taken into account.   
Prediction of Adolescents’ Illness Management  
 
 The second hypothesis examined the prediction of adolescents’ treatment 
adherence and metabolic control.  Specifically, analyses examined the contributions of 
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demographic characteristics, parent-adolescent relationship and illness management 
variables, and adolescents’ executive functioning abilities in predicting the outcome 
variables described above.  Three hierarchical regressions (two predicting adherence and 
one predicting metabolic control) were conducted to examine parent and adolescent-
reported adherence and metabolic control.  In the two regression models assessing the 
contributions of parent- and adolescent-reported variables in the prediction of 
adolescents’ treatment adherence, executive functioning contributed a significant amount 
of unique variance after taking into account related demographic covariates, parental 
involvement and monitoring, and parent-adolescent T1DM-related conflict.  In total, both 
of these models assessing parent and adolescent report of the constructs of interest 
accounted for about 37% of variance in predicting adolescent treatment adherence.  
Research has repeatedly demonstrated the importance of several demographic 
characteristics (e.g., age, ethnicity, method of insulin administration), parental 
involvement and monitoring, and T1DM-related conflict as characteristics that are related 
to illness management among adolescents diagnosed with T1DM (Helgeson et al., 2008; 
Palmer et al., 2004; Miller-Johnson et al., 1994).  The findings in the present study offer 
continued support for all of these factors as significant predictors of adherence but also 
suggests that adolescents’ executive functioning abilities may play an additionally 
important role in aiding in successful T1DM management.  In the final model of both 
regressions, parent- and adolescent-report of parental monitoring and executive 
functioning were the only variables that significantly predicted adherence.  These results 
suggest that in addition to variables assessing family management, such as parental 
monitoring, which has consistently demonstrated a positive association with adolescents’ 
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treatment adherence, perhaps there are cognitive factors that are also important for 
adolescents to successfully manage their T1DM treatment regimen.   
In a regression model assessing the prediction of adolescents’ metabolic control 
using both adolescent- and parent-report variables, adolescents’ reports of their own 
executive functioning abilities (BRIEF-SR Planning and Organization subscale) were not 
found to contribute a significant percentage of unique variance.  The final model 
suggested that length of T1DM diagnosis and parent-adolescent conflict were the only 
significant predictors of adolescents’ HbA1c values.  This finding is consistent with 
previous longitudinal research which has found that improving parent-adolescent conflict 
resulted in better illness management outcomes, especially among older adolescents 
(Ingerski, Anderson, Dolan, & Hood, 2010).   
Examination of the regression models predicting adherence found that T1DM-
related conflict was not a significant predictor; however, conflict did account for a unique 
amount of variance in a regression predicting metabolic control.  It is possible that this 
difference in findings may be a result of the selection of BRIEF and BRIEF-SR subscales 
included in the regressions assessing our two outcome variables.  In analyses assessing 
the prediction of adherence, global executive composite scores were utilized.  In contrast, 
the Planning and Organization subscale was included in analyses predicting metabolic 
control, due to it being the only variable from the BRIEF and BRIEF-SR significantly 
related to HbA1c values at a bivariate level.  Preliminary analyses from this study 
revealed strong associations between global executive composite scores from the BRIEF 
and a measure of parenting stress (Stress Index for Parents of Adolescents (SIPA); 
Sheras, Abidin, & Konold, 1998), suggesting that the index scores from the BRIEF may 
98 
 
also reflect the amount of stress that is present in the home (Fitzgerald, Kichler, Moss, 
Coffey, Heinen, & Kaugars, 2012).  In the regressions assessing the prediction of 
adherence, it is possible that the composite scores from the BRIEF accounted for much of 
the same variance as T1DM-related conflict scores, and as such, conflict was not a 
significant predictor of adherence.   
Moderations Predicting Treatment Adherence  
 
 The third hypothesis in the present study examined several models assessing 
parental monitoring and involvement in T1DM care as potential moderators of the 
relationship between adolescents’ executive functioning and treatment adherence.  
Results indicated that parent-reported involvement served as a significant moderator of 
this relationship, and adolescent-reported parental involvement represented a trend 
towards statistical significance as a moderator.  Further examination of these interactions 
indicated that that the impact of adolescents’ executive functioning on their illness 
management was stronger for adolescents who had lower levels of parental involvement 
with their T1DM care.  These analyses suggest that perhaps in situations where parents 
are less involved in adolescents’ T1DM management, well-developed executive 
functioning abilities may serve as a protective factor for those youth, who have better 
developed cognitive abilities, and as such are able to manage the multiple demands of a 
complex T1DM treatment regimen.  As might be expected, adolescents who 
demonstrated the lowest levels of treatment adherence were those youth with poorly 
developed executive functions who also had parents who were not very involved in 
T1DM care.  In contrast, adolescents who displayed the highest levels of treatment 
adherence tended to have well-developed executive functions but had parents were not 
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very involved in adolescents’ illness management.  This finding suggests that perhaps 
there is a subgroup of adolescents with well-developed executive functions for whom a 
higher level of independent management is advantageous.  It is possible that these youth 
may possess many of the skills necessary to autonomously care for their illness, and 
when parents are less involved there is less parent-adolescent conflict, and better 
adherence to treatment.   
Parental Involvement vs. Parental Monitoring  
 
 Assessment of parental contributions in the illness management of children and 
adolescents has largely focused on measurements of instrumental involvement with care 
tasks and parental monitoring (i.e. parent oversight of care tasks).  Parental involvement 
and monitoring behaviors were both assessed in the present study and each came out as a 
unique predictor in analyses of separate hypotheses.  In analyses examining the 
prediction of adolescent treatment adherence, parental monitoring was a significant 
predictor in the final model; parental involvement did not contribute a significant amount 
of unique variance at any step of the regressions.  However, in the moderational models 
described above, which assessed parental involvement and monitoring as moderators to 
the relationship of adolescents’ adherence and executive functioning, it was the amount 
of parents’ instrumental involvement that served as a significant moderator, rather than 
parental monitoring.  The findings from analyses of these two hypotheses suggests that 
parental oversight and behavioral monitoring are important in aiding adolescents in 
managing their illness regimen; however, for adolescents who have poorly developed 
executive functions, parental monitoring may not be sufficient.  Rather, these youth may 
benefit more from a higher level of instrumental task support and an increase of shared 
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management with parents.  Although there has been much research describing the 
benefits of parental involvement and monitoring as important aspects of T1DM 
management, there is not much research to suggest who is most likely to benefit from 
each.  Most adolescents with T1DM may benefit from, and are able to maintain 
acceptable levels of adherence with parental monitoring of their care tasks; however, 
there is evidence to suggest that for those adolescents with poorer executive functioning 
abilities, they may derive greater benefit from a more hands-on approach from their 
caregivers.     
Relationship of Adherence and Metabolic Control 
 
There were few significant associations in the present study with the measure of 
metabolic control (HbA1c), which was proposed as an outcome variable in two of the 
study hypotheses.  Parent and adolescent reports of adherence on the SCI-R and blood 
glucose record data were significantly correlated with HbA1c, which suggests that 
adolescents who were more adherent to their treatment regimen did in fact demonstrate 
better metabolic control.  This type of finding offers validity to the measures of 
adherence, given that HbA1c values are believed to reflect the average blood glucose 
values from the previous 6-8 weeks.  Previous research has demonstrated a significant 
relationship between the measure of adherence used in the present study (SCI-R) and 
HbA1c values among children and adolescents with T1DM (Kichler, Kaugars, Maglio, & 
Alemzadeh, 2012; Weinger et al., 2005).  The present study finds continuing support for 
the relationship between adherence, as assessed by the SCI-R, and a measure of 
metabolic control.  Research aimed at the prediction of HbA1c values can be challenging, 
given that there are many other factors beyond adherence that contribute to adolescents’ 
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metabolic control.  These include but are not limited to the influx of insulin resistant 
hormones that are secreted as a result of illness or pubertal development (Moreland, 
Tovar, Zuehlke, Butler, Milaszewski, & Laffel, 2004) and psychosocial issues such as 
depression (Grey, Whittemore, & Tamborlane, 2002), which were variables not assessed 
in this study.  Future research should explore the complex associations among executive 
functioning, adherence, and HbA1c.  For example, consistent with a recent study 
examining these constructs among a sample of children, perhaps treatment adherence 
mediates the relationship between executive functioning and glycemic control (McNally 
et al., 2010).  Given the results from the moderational models in the present study, 
mediated moderation analyses should be explored to examine whether parental 
involvement serves a moderating role to the association of executive functioning and 
adherence in a mediation model predicting adolescents’ metabolic control.     
Performance-based vs. Questionnaire Measures of Executive Functioning  
 
 The present study offers several unique contributions to the literature on 
adolescent T1DM management, primarily with data assessing parent and adolescent 
report measures of executive functioning abilities.  In general, there were few significant 
relationships among the outcome variables and neuropsychological measures of 
executive functioning at a bivariate level.  As such, the multivariate analyses were 
conducted with self-reported executive functioning variables and not with the 
neuropsychological data.  There is a paucity of research exploring the convergent validity 
of self-reported and neuropsychological measures of executive functioning.  The few 
studies that have assessed this relationship utilizing samples of children with traumatic 
brain injury, phenylketonuria (PKU), frontal lobe lesions, and hydrocephalus have found 
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very few significant relationships between index scores from the BRIEF and 
performance-based tests of executive function (Anderson, Anderson, Northam, Jacobs, & 
Mikiewicz, 2002; Vriezen & Pigott, 2002).   
This lack of association between self-report and performance-based measures 
would suggest that these measures may be assessing different constructs within the 
executive functioning domain, despite the general assumption that they are measuring 
similar executive behaviors.  As reviewed earlier, one of the primary challenges in 
assessing executive functioning is that it is a complex and multidimensional construct, 
and there continues to be debate among researchers as to most effective way to measure it 
(Wilcutt et al., 2005).  A number of possible explanations may be advanced to account 
for the lack of significant associations among the performance-based measures of 
executive functioning and self-report questionnaires.  One explanation is that 
performance-based neuropsychological measures of executive functioning may lack 
sufficient ecological validity and the sensitivity to assess the diverse nature of situations 
that are experienced in daily life (Barkley & Fischer, 2011).  Performance-based 
measures are typically administered in structured clinical settings and often utilize tasks 
that do not resemble the types of complex problem solving and mental flexibility 
involved in the real world.  Rating scales assessing executive functions may have an 
advantage given that they have the capacity to collect information from multiple 
respondents who can assess the child’s abilities in diverse settings over a longer period of 
time.   
Another possible explanation for the difference in findings between the 
performance and questionnaire measures of executive functioning is that questionnaire 
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measures may be better able to assess the social-cognitive aspects of executive 
functioning as compared to neuropsychological measures.  Although both types of 
measures are able to assess behavioral aspects of executive function including 
impulsivity, problem solving, monitoring, and regulation of performance, there are key 
aspects inherent to most models of executive functioning (e.g., Lezak, 1995) that are 
more difficult for performance-based measures to assess.  Some of these socially-
mediated aspects of executive functioning include assessment of motivation, volition and 
human will, intentionality, and self-awareness (Barkley & Fischer, 2011).  Rating scale 
measures likely offer a more accurate assessment of these aspects and thus may give a 
more comprehensive picture of executive functioning ability.   
As reviewed earlier, most of the significant relationships found between our 
constructs of interest (i.e. treatment adherence and metabolic control) and executive 
functioning measures, were found with the parent and self-report measures of executive 
functioning, rather than with the neuropsychological measures.  It is possible that the 
types of tasks required for managing a diabetes regimen are better assessed by 
questionnaire measures.  With respect to the ecological validity of the neuropsychological 
measures, perhaps negotiating a card sorting or puzzle task does not approximate the 
types of cognitive flexibility and problem solving that are involved in managing T1DM.  
Management of T1DM in daily life is in many ways a “high-stakes” and emotionally 
salient activity that has real-world health consequences for the individual.  Consequently, 
the neuropsychological assessment tools may not mimic this type of “hot” cognition, 
which occurs when an individual is interactive and emotionally invested in the task.  In 
general, self-report measures are more likely to account for adolescents’ behavior across 
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multiple settings and may assess some of the social cognitive aspects of executive 
functioning, which are likely important for managing an illness like T1DM that is 
typically cared for in a family context.  Conversely, it is also possible that we found more 
significant relationships using our parent and self-report measures of executive 
functioning due to issues with common method variance between the BRIEF and our 
primary measure of adherence (i.e. SCI-R).   
Neuropsychological Sequelae of Early Onset Diagnosis 
 
Another interesting finding in the current study, which was not consistent with 
prior research was the lack of significant neurocognitive differences found between our 
samples of adolescents who were diagnosed early in life (prior to age 7) and those 
diagnosed at a later age.  Previous research suggests modest effect size differences in 
several aspects of cognitive functioning, including executive functioning and attention in 
youth with T1DM, when comparing adolescents diagnosed early in life as compared to 
during the school-age period (Gaudieri et al., 2008).  According to Ryan’s (2006) 
diathesis hypothesis, neurocognitive deficits in attention and executive functioning that 
are seen in youth diagnosed at an early age are primarily due to chronic hyperglycemia 
that occurs during critical periods of development, which may create structural and 
functional changes to the CNS and leave the brain vulnerable to later insults.  In the 
current study we did not assess for the frequency and/or severity of hyperglycemia or 
hypoglycemia experienced.  It is possible that we did not have a large enough sample to 
detect these effects, which typically are modest, and do not represent gross 
neurocognitive dysfunction.   
Clinical Implications 
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The present research study findings have several potential clinical implications 
that may play a role in improving the illness management of adolescents with T1DM.  
Overall, the study finds support for measuring executive functioning abilities in 
adolescents with T1DM as a potentially important contributing factor in aiding 
adolescents with the complex management of this illness.  Given that the study found 
significant relationships among self- and parent-reported measures of executive 
functioning and our measures of adherence, it may be of benefit to administer a measure 
such as the BRIEF and/or BRIEF-SR to families in periodic clinic visits.  This type of 
assessment would likely be most beneficial in early adolescence as parents and 
adolescents are beginning to transition illness care responsibilities.  The present study 
would suggest that this brief assessment may offer insight to identify those adolescents in 
need of additional parental support.  Parents are often less willing to provide additional 
support to older adolescents based on the belief that as emerging adults they need to learn 
to be autonomous in their management (Palmer et al., 2004).  This study suggests that 
perhaps there is a subgroup of adolescents who have poorer executive functioning and 
who may benefit from a higher level of shared management.   Additionally, well-
developed executive functions may serve as a protective factor for adolescents in 
situations where parents are somewhat disengaged from illness management and who are 
not able or not willing to offer much support. 
Limitations and Future Directions 
 
There were several limitations to the current study, which may limit the 
generalizability of the findings.  One of the limitations was that the study was a cross-
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sectional design and thus represents only a snapshot of adolescents’ cognitive 
functioning, treatment adherence, and responsibility sharing of diabetes care; therefore, 
the results describe relationships among variables and not causality.  For example, it is 
not clear from the data whether adolescents have a difficult time adhering to a complex 
diabetes regimen because they have poorly developed executive functions or whether 
chronic non-adherence has an effect on the development of adolescents’ executive 
functioning abilities.  Additionally, with a cross-sectional design it is unclear how parents 
adjust their involvement in children’s and adolescents’ diabetes management over time as 
adolescents develop more advanced problem solving abilities.  A longitudinal study that 
examines these processes over time would be advantageous and would give a more 
accurate picture of the evolving process of shared family management.  Miller et al. 
(2012) conducted a longitudinal study examining changes in executive functioning 
among children (ages 9-11) and found that the Behavioral Regulation Index on the 
BRIEF predicted changes in treatment adherence over a two- year period.  Given the 
marked frontal lobe and executive functioning development that has been found to occur 
over the course of adolescence, similar longitudinal research with a sample of adolescents 
would provide important information to better understand self-care and transition into 
emerging adulthood.  To the best of our knowledge, there has not been much research 
exploring the role of cognitive functions in the transition that occurs from pediatric to 
adult care, which is an area that is gaining increasing attention in the literature.   
Another limitation of the current study was that the sample was largely Caucasian 
and middle to upper class socioeconomic status.  The percentage of Caucasian families is 
somewhat higher than the percentage in the CHW diabetes clinic population (85% 
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Caucasian).  Some differences in family and cognitive functioning were noted among 
ethnically diverse adolescents, compared to the Caucasian adolescents in our study; 
however, given the largely homogenous nature of the sample, there was not enough 
statistical power to further explore these effects.  Consequently, the generalizability of 
our findings to populations with different demographic characteristics is limited.  Future 
research in this area should examine these questions with a more diverse sample with 
respect to ethnicity and socioeconomic status.   
An additional limitation to the study design includes the reliance on self-report 
questionnaires to measure many constructs including the assessment of parental 
involvement and monitoring, parent-adolescent conflict, and adolescents’ mental health.  
As reviewed earlier, there are issues with common method variance for many of the 
significant findings in the current study.  Another limitation in the current study is that 
multivariate analyses examined the self-report data within-reporters, meaning that 
regressions were conducted separately with parents’ and adolescents’ data.  Further 
analyses should be conducted examining similar predictive models across reporters and 
utilizing dyadic analyses to account for the perspectives of multiple responders.   
Given the integral role that executive functions play in ADHD, the study would 
likely have benefited from a more thorough assessment of ADHD symptomology, rather 
than reliance on parent-report of diagnosis (Barkley & Fischer, 2011).  A diagnostic 
measure of ADHD symptoms would provide a more accurate assessment of the presence 
of this diagnosis.  Adolescents with ADHD are at greater risk for experiencing executive 
dysfunction and consequently may benefit from early identification of symptoms and 
additional assistance with T1DM management.  In the current study, about 9% of 
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participants were identified as having diagnoses of ADHD, which is generally consistent 
with population base rates, and as such, they were included in analyses.  They were 
included in analyses to  were included in analyses   Similarly, research suggests that 
adolescents with T1DM are more likely than healthy adolescents to be diagnosed with 
depression and anxiety (Grey et al., 2002), which have been associated with poorer 
treatment adherence and metabolic control (Dabadghao, Vidmar, & Cameron, 2001).  
Measurement of these constructs would have offered a more comprehensive assessment 
in the prediction of adolescents’ treatment adherence and metabolic control.  
Additionally, depression and anxiety often have an adverse effect on attention and 
concentration, which on formal testing, may be mistaken as an deficit in executive 
functioning ability.   
Conclusion  
 
In conclusion, the results of the current study find support for the association 
between parent- and self-reported executive functioning and treatment adherence among 
adolescents with T1DM.  Specifically, parental involvement was found to be a significant 
moderator of the relationship between adherence and executive functioning, suggesting 
that adolescents’ executive functioning had a greater impact when parents were less 
involved in adolescents’ illness care.  This finding suggests that it may be important for 
healthcare professionals to assess adolescents’ executive functioning abilities in order to 
identify those youth who may be in the most need for continued parental involvement.  
Specific targets of intervention could focus on improving adolescents’ problem solving 
and planning abilities to assist youth in developing some of the skills that appear to be 
necessary for successful T1DM management.  Future longitudinal research will be 
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important to assess the developmental trajectory of executive functioning abilities to 
determine the ways that parents and adolescents negotiate shared management of T1DM 
care across the adolescent years.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110 
 
BIBLIOGRAPHY 
Aiken, L.S. & West, S.G.  (1991). Multiple regression:  Testing and interpreting 
interactions.  Newbury Park, CA: Sage. 
 
American Diabetes Association.  (2008).  Standards of medical care in diabetes.  
Diabetes Care, 21, S12-S53.  doi:10.2337/dc08-S012 
 
Anderson, B.J., Auslander, W.F., Jung, K.C., Miller, P., & Santiago, J.V.  (1990).   
Assessing family sharing of diabetes responsibilities.  Journal of Pediatric 
Psychology, 15(4), 477- 492.  doi:10.1093/jpepsy/15.4.477  
 
Anderson, B., Ho, J., Brackett, J., Finkelstein, D., & Laffel, L.  (1997). Parental 
involvement in diabetes management tasks:  Relationships to blood glucose 
monitoring adherence and metabolic control in young adolescents with insulin-
dependent diabetes mellitus.  The Journal of Pediatrics, 130(2), 257-265.  
doi:10.1016/S0022-3476(97)70352-4 
 
Anderson, B,J., Holmbeck, G., Iannotti, R.J., McKay, S.V., Lochrie, A., Volkening, L.K., 
& Laffel, L.  (2009).  Dyadic measures of the parent-child relationship during the 
transition to adolescence and glycemic control in children with type 1 diabetes.  
Families, Systems, & Health, 27(2), 141-152. doi:10.1037/a0015759 
 
Anderson, B.J., Vangsness, L., Connell, A., Butler, D., Goebel-Fabbri, A., & Laffel, 
L.M.B. (2002).  Family conflict, adherence, and glycemic control in youth with 
short duration type 1 diabetes.  Diebetic Medicine, 19, 635-642. 
doi:10.1046/j.1464-5491.2002.00752.x 
 
Anderson, P.J. (2008).  Towards a developmental model of executive function.  In V. 
Anderson, Jacobs, R., & Anderson, P.J. (Eds.), Executive functions and the frontal 
lobes (pp.3-21). New York: Taylor & Francis Group.   
 
Anderson, V.  (2002).  Executive function in children: An introduction.  Child 
Neuropsychology, 8, 69-70.  doi: 10.1076/chin.8.2.69.8725 
 
Anderson, V., Anderson, P.J., Jacobs, R., & Smith, M.S.  (2008).  Development and 
assessment of executive function:  From preschool to adolescence.  In V. 
Anderson, Jacobs, R., & Anderson, P.J. (Eds.), Executive functions and the frontal 
lobes (pp.3-21). New York: Taylor & Francis Group.   
 
Anderson, V.A., Anderson, P., Northam, E., Jacobs, R., & Mikiewicz, O. (2002).  
Relationships between cognitive and behavioral measures of executive 
functioning in children with brain disease.  Child Neuropsychology, 8(4), 231-
240. doi:10.1076/chin.8.4.231.13509 
111 
 
Ardila, A., Pineda, D., & Rosselli, M.  (2000). Correlation between intelligence scores 
and executive function measures.  Archives of Clinical Neuropsychology, 15(1), 
31-36.  doi:10.1016/S0887-6177(98)00159-0  
 
Axelrod, B.N., Goldman, R.S., & Woodward, J.L. (1992).  Interrater reliability in scoring 
the Wisconsin Card Sorting Test.  The Clinical Neuropsychologist, 6, 143-155. 
doi:10.1080/13854049208401851 
 
Baddeley, A.D.  (1986). Working memory.  Oxford:  Oxford University Press. 
 
Bagner, D.M., Williams, L.B., Geffken, G.R., Silverstein, J.H., & Storch, E.A. (2007).  
Type 1 diabetes in youth:  The relationship between adherence and executive 
functioning.  Children’s Health Care, 36(2), 169-179.  
doi:10.1080/02739610701335001 
 
Baldo, J.V., Shimamura, A.P., Delis, D.C., Kramer, J., & Kaplan, E. (2001).  Verbal and  
design fluency in patients with frontal lobe lesions.  Journal of International 
Neuropsychological Society, 7, 586-596. doi:10.1017/S1355617701755063 
 
Barber, B.K.  (2002). Intrusive parenting:  How psychological control affects children 
and adolescents.  Washington, DC:  American Psychological Association. 
 
Barkai, L., Vamosi, I., & Lukacs, K.  (1998).  Prospective assessment of severe 
hypoglycaemia in diabetic children and adolescents with impaired and normal 
awareness of hypoglycaemia.  Diabetologia, 41, 898-903.  
doi:10.1007/s001250051005 
 
Barkley, R.A. & Fischer, M. (2011). Predicting impairments in major life activities and  
occupational functioning in hyperactive children as adults:  Self-reported 
executive function (EF) deficits.  Developmental Neuropsychology, 36(2), 137-
161. doi:10.1080/87565641.2010.549877 
 
Barkley, R. A. & Murphy, K.R. (2011).  The nature of executive functioning (EF) deficits 
in daily life activities in adults with ADHD and their relationship to EF tests.  
Journal of Psychopathology and Behavioral Assessment, 22(2), 137-158. 
doi:10.1007/s10862-011-9217-x 
 
Baron, R.M., & Kenney, D.A.  (1986). The moderator-mediator variable distinction in 
social psychological research:  Conceptual, strategic, and statistical 
considerations.  Journal of Personality and Social Psychology, 51, 1173-1182.  
doi:10.1037/0022-3514.51.6.1173 
 
Beaser, R.S. (Ed.).  (2007).  Joslin’s diabetes deskbook (2nd ed.).  Boston:  Joslin 
Diabetes Center.   
 
Benton, A. L., Hamsher, K., & Sivan, A. B. (1994). Multilingual Aphasia Examination  
112 
 
 (3rd ed.). Iowa City, IA:  AJA Associates. 
 
Bjorgass, M., Gimse, R., Vik, T., & Sand, T.  (1997).  Cognitive function in type 1 
children with diabetes with and without episodes of severe hypoglycemia.  Acta 
Pediatrica, 86, 148-153. doi:10.1111/j.1651-2227.1997.tb08856.x 
 
Bismuth, E. & Laffel, L.M.  (2007). Treatment of children with diabetes.  In R.S. Beaser 
(Ed.), Joslin’s diabetes deskbook (2nd ed, pp. 595-622). Boston:  Joslin Diabetes 
Center.   
 
Blakemore, S. & Choudhury, S.  (2006). Development of the adolescent brain:  
Implications for executive function and social cognition.  Journal of Child 
Psychology and Psychiatry, 47(3/4), 296-312.  doi:10.1111/j.1469-
7610.2006.01611.x 
 
Christensen, A.J. (2004).  Patient adherence to medical treatment regimens.  New Haven, 
CT: Yale University Press. 
 
Cook, S., Herold, K., Edidin, D.V., & Briars, R.  (2002).  Increasing problem solving in 
adolescents with type 1 diabetes:  The choices program.  The Diabetes Educator, 
28(1), 115-124.  doi:10.1177/014572170202800113 
 
Cooper, C.R. (1988). Commentary: The role of conflict in adolescent-parent  
relationships. In M.R. Gunnar, & W.A. Collins (Eds.), Development during 
transition to adolescence. Minnesota Symposia on Child Psychology (Vol. 21, 
pp.181-187). Hillsdale, NJ: Erlbaum. 
 
Cox, D.J., & Gonder-Frederick, L.  (1992). Major developments in behavioural diabetes 
research.  Journal of Consulting and Clinical Psychology, 60, 628-638. 
doi:10.1037/0022-006X.60.4.628 
 
Dabadghao, P., Vidmar, S., & Cameron, F.J. (2001). Deteriorating diabetic control  
through adolescence – do the origins lie in childhood? Diabetes Medicine, 18, 
889-894. doi:10.1046/j.1464-5491.2001.00593.x 
 
Dahl, R. E. (2001). Affect regulation, brain development, and behavioral/emotional  
 health in adolescence. CNS Spectrums, 6(1), 60-72. 
 
Dashiff, C.J. (2003).  Self- and dependent-care responsibility of adolescents with IDDM  
and their parents.  Journal of Family Nursing, 9(2), 166-183. doi: 
10.1177/1074840703009002004 
 
Delis, D.C., Kaplan, E., & Kramer, J.H. (2001a).  The Delis Kaplan Executive 
Functioning System:  Examiner’s Manual.  San Antonio, TX:  The Psychological 
Corporation. 
113 
 
Delis, D.C., Kaplan, E., & Kramer, J.H. (2001b).  The Delis Kaplan Executive 
Functioning System:  Technical Manual.  San Antonio, TX:  The Psychological 
Corporation. 
 
Desrocher, M. & Rovet, J.  (2004). Neurocognitive correlates of type 1 diabetes mellitus 
in childhood.  Child Neuropsychology, 10(1), 36-52.  
doi:10.1076/chin.10.1.36.26241 
 
Diabetes Control and Complications Trial (DCCT; 1994).  Effect of intensive diabetes  
treatment on the development and progression of long-term complications in 
adolescents with insulin dependent diabetes mellitus:  Diabetes Control and 
Complications Trial Research Group.  Journal of Pediatrics, 125(2), 177-188. 
doi: 10.1016/S0022-3476(94)70190-3 
 
DiMatteo, M.R. (2004).  The role of effective communication with children and their 
families in fostering adherence to pediatric regimens.  Patient Education and 
Counseling, 55, 339-344. doi:10.1016/j.pec.2003.04.003 
 
DiMatteo, M.R., Giordani, P.J., Lepper, H.S., & Croghan, T.W. (2002).  Patient  
adherence and medical treatment outcomes:  A meta-analysis.  Medical Care, 
40(9), 794-811. doi: 10.1097/01.MLR.0000024612.61915.2D 
 
Duff, K., Schoenberg, M.R., Scott, J.G., & Adams, R.L. (2005).  The relationship  
between executive functioning and verbal and visual learning and memory.  
Archives of Clinical Neuropsychology, 20(1), 111-122. 
doi:10.1016/j.acn.2004.03.003 
 
Ellis, D.A., Podolski, C.L., Frey, M., Naar-King, S., Wang, B., & Moltz, K. (2007).  The  
role of parental monitoring in adolescent health outcomes: Impact on regimen 
adherence in youth with type 1 diabetes.  Journal of Pediatric Psychology, 32, 
907–917. doi:10.1093/jpepsy/jsm009 
 
Ellis, D. A., Templin, T., Naar-King, S., & Frey, M. (2008). Toward conceptual clarity in 
 a critical parenting construct: Parental monitoring in youth with chronic illness.   
 Journal of Pediatric Psychology, 33(8), 799–808. doi:10.1093/jpepsy/jsn044 
 
Erdfelder, E., Faul, F.,  & Buchner, A.  (1996). G*Power:  A general power analysis 
program.  Behavior Research Methods, Instruments, and Computing, 28, 1-11. 
doi:10.3758/BF03203630 
 
Fairclough, S.H. & Houston, K. (2004).  A metabolic measure of mental effort.  
Biological Psychology, 66, 177-190.  doi:10.1016/j.biopsycho.2003.10.001 
 
Ferguson, S.C., Blane, A., Wardlaw, J., Frier, B.M., Perros, P., McCrimmon, R.J., & 
Deary, I.J. (2005).  Influence of an early-onset age of type 1 diabetes on cerebral 
114 
 
structure and cognitive function.  Diabetes Care, 28(6), 1431-1437. 
doi:10.2337/diacare.28.6.1431 
 
Fitzgerald, C.J., Kichler, J., Moss, A., Coffey, M., Heinen, A., & Kaugars, A.S. (2012,  
February).  An exploration of executive functioning among adolescents with type 1 
diabetes mellitus.  Paper presented at the 2012 Pediatric Behavioral Health 
Research Conference:  Inspiring Collaboration in Research, Milwaukee, WI. 
 
Gailliot, M.T. & Baumeister, R.F.  (2007).  The physiology of willpower:  Linking blood 
glucose to self-control.  Personality and Social Psychology Review, 11(4), 303-
327. doi:10.1177/1088868307303030 
 
Gaudieri, P.A., Greer, T.F., Chen, R., & Holmes, C.S. (2008).  Cognitive function in 
children with type 1 diabetes.  Diabetes Care, 31(9), 1892-1897. 
doi:10.2337/dc07-2132 
 
Giedd, J.N. (2004).  Structural magnetic resonance imaging of the adolescent brain.  
Annals of the New York Academy of Sciences, 1021, 77-85. 
doi:10.1196/annals.1308.009 
 
Giedd, J.N., Blumenthal, J., Jeffries, N.O., Castellanos, F.X., Liu, H., Zijdenbos, A., … 
Rapoport, J.L. (1999).  Brain development during childhood and adolescence:  A 
longitudinal MRI study.  Nature Neuroscience, 2, 861-863. doi:10.1038/13158 
 
Gioia, G.A., Isquith, P.K., Guy, S.C., & Kenworthy, L.  (2000). Behavior Rating 
Inventory of Executive Function. Child Neuropsychology, 6(3), 235-238. 
doi:10.1076/chin.6.3.235.3152 
 
Glasgow, R.E., McCaul, K.D., & Schafer, L.C. (1987).  Self care behaviors and glycemic 
control in type 1 diabetes.  Journal of Chronic Disabilities, 40(5), 399-412. 
doi:10.1016/0021-9681(87)90173-1 
 
Glasgow, A.M., Weissberg-Benchell, J., Tynan, W.D., Epstein, S.F., Driscoll, C., Turek, 
J, & Beliveau, E. (1991).  Readmissions of children with diabetes mellitus to a 
children’s hospital.  Pediatrics, 88(1), 98-104.  
 
Golden, M.P. (1999).  Special problems with children and adolescents with diabetes.  
Primary Care, 26(4), 885-893. doi:10.1016/S0095-4543(05)70137-8 
 
Greco, P., LaGreca, A.M., Ireland, S.J., Wick, P., Freeman, C., Agramonte, R., … Skyler, 
J. (1990).  Assessing adherence in IDDM:  A comparison of two methods.  
Diabetes, 39(Suppl. 1), 165. 
 
Greening, L., Stoppelbein, L., & Reeves, C.B.  (2006).  A model for promoting 
adolescents’ adherence to treatment for type 1 diabetes mellitus.  Children’s 
Health Care, 35(3), 247-267. doi:10.1207/s15326888chc3503_4 
115 
 
Grey, M., Whittemore, R., & Tamborlane, W. (2002). Depression in type 1 diabetes in  
children: Natural history and correlates.  Journal of Psychosomatic Research, 
53(4), 907-911. doi:10.1016/S0022-3999(02)00312-4 
 
Guy, S. C., Isquith, P. K., & Gioia, G. A.  (2004). Behavior Rating Inventory of Executive  
 Function-Self Report version.  Lutz, FL: Psychological Assessment Resources. 
 
Hanna, K.M., DiMeglio, L.A., & Fortenberry, J.D.  (2005).  Brief report:  Initial testing  
of scales measuring parent and adolescent perceptions of adolescents’ assumption 
of diabetes management.  Journal of Pediatric Psychology, 32(3), 245-249. 
doi:10.1093/jpepsy/jsl006 
 
Harris, M.A., Wysocki, T., Sadler, M., Wilkinson, K., Harvey, L.M., Buckloh, L.M.,  
…White,  N.H.  (2000). Validation of a structured interview for the assessment of 
diabetes self-management.  Diabetes Care, 23, 1301-1304. 
doi:10.2337/diacare.23.9.1301 
 
Haynes, R.  (1979). Introduction.  In R. Haynes, D. Taylor, & D. Sackett (Eds.),  
Compliance in health care (pp. 2-3).  Baltimore, MD:  Johns Hopkins University 
Press. 
 
Heaton, S. K., Chelune, G. J., Talley, J. L., Kay, G. G., & Curtiss, G. (1993). Wisconsin  
Card Sorting Test manual: Revised and expanded. Odessa, FL: Psychological 
Assessment Resources. 
 
Helgeson, V.S., Reynolds, K.A., Siminerio, L., Escobar, O., & Becker, D. (2008).  Parent 
and adolescent distribution of responsibility for diabetes self-care:  Links to health 
outcomes.  Journal of Pediatric Psychology, 33(5), 497-508. 
doi:10.1093/jpepsy/jsm081 
 
Hood, K.K., Butler, D.A., Anderson, B.J., & Laffel, L.M. (2007).  Updated and revised  
Diabetes Family Conflict Scale.  Diabetes Care, 30(7), 1764-1769. 
doi:10.2337/dc06-2358 
 
Hood, K.K., Peterson, C.M., Rohan, J.M., & Drotar, D. (2010).  Association between  
adherence and glycemic control in pediatric type 1 diabetes:  A meta-analysis.  
Pediatrics, 124(6), 1171-1179. doi:10.1542/peds.2009-0207   
 
Ingerski, L.M., Anderson, B.J., Dolan, L.M., & Hood, K.K. (2010).  Blood glucose  
monitoring and glycemic control in adolescence:  Contributions of diabetes-
specific responsibility and family conflict.  Journal of Adolescent Health, 47(2), 
191-197. doi:10.1016/j.jadohealth.2010.01.012 
 
Jacobson, A.M., Hauser, S.T., Lavori, P., Willett, J.B., Cole, C.F., Wolfsdorf, 
J.I.,…Wertlieb, D. (1994).  Family environment and glycemic control: A four-
year prospective study of children and adolescents with insulin-dependent 
116 
 
diabetes mellitus.  Psychosomatic Medicine, 56, 401-409.  doi: 0033-
3174/94/5605-0401  
 
Johnson, S.B. (1993).  Chronic diseases of childhood:  Assessing compliance with  
complex medical regimens.  In N.A. Krasnegor, L. Epstein, S.B. Johnson, & S.J. 
Yaffe (Eds.), Developmental aspects of health compliance behavior (pp. 157-
184).  Hillsdale, NJ: Lawrence Erlbaum Associates. 
 
Johnson, S.B. (1994).  Health behavior and health status:  Concepts, methods, and  
applications.  Journal of Pediatric Psychology, 19, 129-141. 
doi:10.1093/jpepsy/19.2.129 
 
Kaufman, F.R., Epport, K., Engilman, R., & Halvorson, M.  (1999). Neurocognitive 
functioning in children diagnosed with diabetes before age 10 years.  Journal of 
Diabetes and its Complications, 13, 31-38.  doi:10.1016/S1056-8727(98)00029-4 
 
Kichler, J.C, Kaugars, A.S., MAglio, K., & Alemzadeh, R.  (2012). Exploratory analysis 
of the relationships among different methods of assessing adherence and glycemic 
control in youth with type 1 diabetes mellitus.  Journal of Health Psychology, 
31(1), 35-42. doi: 10.1037/a0024704 
 
Kinsella, G., Storey, E., & Crawford, J.R.  (2006). Executive function and its assessment.  
In A.  Schapira (Ed.), Neurology and clinical neuroscience (pp.83-95).  New 
York: Mosby.  
 
Klimkeit, E.I., Mattingley, J.B., Sheppard, D.M., Farrow, M., & Bradshaw, J.L. (2004). 
Examining the development of attention and executive functions in children with 
a novel paradigm.  Child Neuropsychology, 10(3), 201-211. 
doi:10.1080/09297040490911050 
 
Kyngäs, H. A., Kroll, T., & Duffy, M. E. (2000). Compliance in adolescents with chronic  
diseases: A review.  Journal of Adolescent Health, 26(6), 379-388.  
doi: S1054-139X(99)00042-7 
 
La Greca, A.M. & Bearman, K.J. (2003). Adherence to pediatric treatment regimens. In  
M.C. Roberts (Ed.), Handbook of pediatric psychology (3
rd
 ed., pp.119-140). New 
York: Guilford Press. 
 
Laursen, B.  (1993). The perceived impact of conflict of on adolescent relationships.   
 Merrill-Palmer Quarterly, 39(4), 535-550.   
 
Lehmkuhl, H.D., Merlo, L.J., Storch, E.A., Heidgerken, A., Silverstein, J.H., & Geffken, 
G.R. (2009).  Cognitive abilities in a sample of youth with multiple episodes of 
diabetic ketoacidosis.  Journal of Developmental Physical Disabilities, 21, 1-8.  
doi:10.1007/s10882-008-9121-9 
 
117 
 
Lemanek, K. (1990).  Adherence issues in the medical management of asthma.  Journal  
 of Pediatric Psychology, 15(4), 437-458. doi:10.1093/jpepsy/15.4.437 
 
Levin, H.S., Song, J., Scheibel, R.S., Fletcher, J.M., Harvard, H., Lilly, M., & Goldstein,  
F. (1997). Concept formation and problem-solving following closed head injury 
in children.  Journal of the International Neuropsychological Society, 3(6), 598-
607.   
 
Levine, B. S., Anderson, B. J., Butler, D. A., Brackett, J.,& Laffel, L. (2001). Predictors  
of glycemic control and short-term adverse outcomes in youth with type 
1diabetes. Journal of Pediatrics, 139, 197–203. doi:10.1067/mpd.2001.116283 
 
Lewin, A.B., La Greca, A.M., Geffken, G.R., Williams, L.B., Duke, D.C., Storch, E.A.,  
& Silverstein, J.H. (2009).  Validity and reliability of an adolescent and parent 
rating scale of type 1 diabetes adherence behaviors:  The Self-Care Inventory.  
Journal of PediatricPsychology, 34(9), 999-1007. doi:10.1093/jpepsy/jsp032 
 
Lezak, M.D.  (1995). Neuropsychological assessment.  Oxford:  Oxford University Press. 
 
Li, X., Stanton, B., & Feigelman, S. (2000). Impact of perceived parental monitoring on  
adolescent risk behavior over 4 years.  Journal of Adolescent Health, 27, 49-56.  
doi:10.1016/S1054-139X(00)00092-6 
 
Luciana, M. & Nelson, C.A. (2002).  Assessment of neuropsychological function through  
use of The Cambridge Neuropsychological Testing Automated Battery:  
Performance in 4-12 year-old children.  Developmental Neuropsychology, 22(3), 
595-624. doi:10.1207/S15326942DN2203_3 
 
Luria, A. (1973).  The working brain.  New York:  Basic Books.  
 
McCloskey, G., Perkins, L.A., & Van Divner, B.  (2009). Assessment and intervention  
 for executive function difficulties.  New York:  Routledge Publishers.   
 
McGivern, R.F., Anderson, J., Byrd, D., Mutter, K.L., & Reilly, J. (2002).  Cognitive  
efficiency on a match to sample task decreases at the onset of puberty in children.  
Brain and Cognition, 50, 73-89. doi:10.1016/S0278-2626(02)00012-X 
 
McNally, K., Rohan, J., Shroff Pendley, J., Delamater, A., & Drotar, D.  (2010).  
Executive functioning, treatment adherence, and glycemic control in children with 
type 1 diabetes.  Diabetes Care, 33(6), 1159-1162. doi:10.2337/dc09-2116 
 
Meyer, S.E., Carlson, G.A., Wiggs, E.A., Martinez, P.E., Ronsaville, D.S., Kilmes- 
Dougan, B.,… Radke-Yarrow, M. (2004).  A prospective study of the association 
among impaired executive functioning, childhood attentional problems, and the 
development of bipolar disorder.  Development and Psychopathology, 16, 261-
476.  doi:10.10170S095457940404461X 
118 
 
Meyers, J. & Meyers, K. (1995).  Rey Complex Figure and the recognition trial: 
Professional manual. Odessa, FL:  Psychological Assessment Resources.   
 
Meyers, J. & Meyers, K. (1996).  The Meyers scoring system for the Rey Complex Figure 
and the recognition trial: Professional manual.  Supplemental norms for children 
and adolescents.  Odessa, FL:  Psychological Assessment Resources.   
 
Miller, V.A., & Drotar, D. (2003).  Discrepancies between mother and adolescent  
perceptions of diabetes-related decision-making autonomy and their relationship 
to diabetes-related conflict and adherence to treatment.  Journal of Pediatric 
Psychology, 28(4), 265-274.  doi:10.1093/jpepsy/jsg014 
 
Miller, V.A., & Drotar, D. (2007).  Decision-making competence and adherence to  
treatment in adolescents with diabetes.  Journal of Pediatric Psychology, 32(2), 
178-188. doi:10.1093/jpepsy/jsj122 
 
Miller, M.M., Rohan, J.M., Delamater, A., Shroff Pendley, J., Dolan, L.M., Reeves, G.,  
Drotar. D. (2012). Changes in executive functioning and self-management in 
adolescents with type 1 diabetes:  A growth curve analysis.  Journal of Pediatric 
Psychology, 38(1), 18-29. doi:10.1093/jpepsy/jss100 
 
Miller-Johnson, S., Emery, R.E., Marvin, R.S., Clarke, W., Lovinger, R., & Martin, M.   
(1994).  Parent-child relationships and the management of insulin-dependent 
diabetes mellitus.  Journal of Consulting and Clinical Psychology, 62(3), 603-
610. doi:10.1037/0022006X.62.3.603 
 
Milner, B.  (1982). Some cognitive effects of frontal-lobe lesions in man.  Philosophical 
Transactions of the Royal Society of London, 298, 211-226. 
doi:10.1098/rstb.1982.0083  
 
Moos, R.H.  (1986). Family Environment Scale manual.  Palo Alto, CA:  Consulting 
Psychologists Press.  
 
Montemayor, R. & Hanson, E.  (1985). A naturalistic view of conflict between 
adolescents and their parents and siblings.  Journal of Early Adolescence, 5(1), 
23-30. doi:10.1177/0272431685051003 
 
Moreland, E.C., Tovar, A., Zuehlke, J.B., Butler, D.A., Milaszewski, K., & Laffel, L.M.   
(2004).  The impact of physiological, therapeutic, and psychosocial variables on 
glycemic control in youth with type 1 diabetes mellitus.  Journal of Pediatric 
Endocrinology and Metabolism, 17(11), 1533-1544. 
doi:10.1515/JPEM.2004.17.11.1533 
 
Musen, G., Jacobson, A.M., Ryan, C.M., Cleary, P.A., Waberski, B.H., Weinger, 
K.,…White, N. (2008).  Impact of diabetes and its treatment on cognitive function 
119 
 
among adolescents who participated in the diabetes control and complications 
trial.  Diabetes Care, 31(10), 1933-1938. doi:10.2337/dc08-0607 
 
Myers, L. & Midence, K. (Eds.). (1998). Adherence to treatment in medical conditions.  
Newark, NJ: Gordon & Breach. 
 
Niloufar Salimpoor, V. & Desrocher, M.  (2006). Increasing the utility of EF assessment 
of executive function in children.  Developmental Disabilities Bulletin, 34(1/2), 
15-42.   
 
Noack, P., & Buhl, H.M.  (2005).  Relations with parents and friends during adolescence 
and early adulthood.  Marriage and Family Review, 36(3/4), 31-51.  
doi:10.1300/J002v36n03_03 
 
Norman, D.A. & Shallice, T.  (1986). Attention to action:  Willed and automatic control 
of behavior.  In R.J. Davidson, G.E. Schwartz, & D.E. Shapiro (Eds.), 
Consciousness and self-regulation (Vol. 4, pp. 1-14). New York:  Plenum Press.   
 
Palmer, D.L., Berg, C.A., Wiebe, D.J., Beveridge, R.M., & Korbel, C.D.  (2004). The 
role of autonomy and pubertal status in understanding age differences in maternal 
involvement in diabetes responsibility across adolescence.  Journal of Pediatric 
Psychology, 29(1), 35-46. doi:10.1093/jpepsy/jsh005 
 
Patterson, G. R., Capaldi, D., & Bank, L. (1991). An early starter model for predicting 
delinquency. In D. J. Pepler & K. H. Rubin (Eds.), The development and 
treatment of childhood aggression (pp. 139-168). Hillsdale, NJ: Lawrence 
Erlbaum Associates. 
 
Paus, T. (2005). Mapping brain maturation and cognitive development during 
adolescence.  Trends in Cognitive Neuroscience, 9, 60-68. 
doi:10.1016/j.tics.2004.12.008 
 
Pereira, M.G., Berg-Cross, L., Almeida, P., & Machado, J,C.  (2008).  Impact of family 
environment and support on adherence, metabolic control, and quality of life in 
adolescents with diabetes.  International Journal of Behavioral Medicine, 15(3), 
187-193. doi:10.1080/10705500802222436 
 
Quittner, A.L., Espelage, D.L., Ievers-Landis, C., & Drotar, D. (2000).  Measuring 
adherence to medical treatments in childhood chronic illness: Considering 
multiple methods and sources of information.  Journal of Clinical Psychology in 
Medical Settings, 7(1), 41-54. doi: 1068-9583/00/0300-0041 
 
Quittner, A.L., Modi, A.C., Lemanek, K.L., Ievers-Landis, C.E., & Rapoff, M.A. (2008).  
Evidence-based assessment of adherence to medical treatments in pediatric 
psychology.  Journal of Pediatric Psychology, 33(9), 916-936. 
doi:10.1093/jpepsy/jsm064 
120 
 
Rakic, P., Bourgeois, J.P., & Goldman-Rakic, P.S. (1994).  Synaptic development of the  
cerebral cortex:  Implications for learning, memory, and mental illness.  
Progressive Brain Research, 102, 227-242. doi:10.1016/S0079-6123(08)60543-9 
 
Rapoff, M.A. (2010).  Adherence to pediatric medical regimens (2
nd
 ed.). New York:  
 Springer Science. 
 
Rodgers, K.B. & Rose, H.A. (2001).  Personal, family, and school factors related to  
adolescent academic performance:  A comparison by family structure.  Marriage 
& Family Review, 33, 47-61. doi:10.1300/J002v33n04_05 
 
Rovet, J. & Alvarez, M. (1997). Attentional functioning in children and adolescents with  
IDDM.  Diabetes Care, 20, 803-810. doi:10.2337/diacare.20.5.803 
 
Rovet, J.F., Ehrlich, R.M., Czuchta, D., & Akler, M.  (1993). Psychoeducational  
characteristics of children and adolescents with insulin-dependent diabetes 
mellitus.  Journal of Learning Disabilities, 26, 7-22. 
doi:10.1177/002221949302600102 
 
Ryan, C.M.  (2006). Why is cognitive dysfunction associated with the development of 
diabetes early in life?  The diathesis hypothesis.  Pediatric Diabetes, 7, 289-297. 
doi:10.1111/j.1399-5448.2006.00206.x  
 
Ryan, C.M., Atchison, J., Puczynski, S., Puczynski, M., Arslanian, S., & Becker, D.   
(1990).  Mild hypoglycemia associated with deterioration of mental efficiency in 
children with insulin-dependent diabetes mellitus.  Journal of Pediatrics, 117, 32-
38. doi:10.1016/S0022-3476(05)82440-0 
 
Sansbury, L., Brown, R.T., & Meacham, L.  (1997).  Predictors of cognitive functioning  
 in children with insulin-dependent diabetes mellitus:  A preliminary investigation.   
Children’s Health Care, 26, 197-210. doi:10.1207/s15326888chc2603_5 
 
Schilling, L., Knafl, K., & Grey, M. (2006).  Changing patterns of self-management in  
youth with type 1 diabetes.  Journal of Pediatric Nursing, 21(6), 412-424. 
doi:10.1016/j.pedn.2006.01.034 
 
Shallice, T. (1982). Specific impairments of planning. Philosophical Transactions of the  
 Royal Society of London, B298, 199-209. doi:10.1098/rstb.1982.0082 
 
Sheras, P.L., Abidin, R.R., & Konold, T.R. (1998).  SIPA: Stress Index for Parents of  
Adolescents:  Professional Manual.  Lutz, FL:  Psychological Assessment 
Resources Inc. 
 
Sowell, E.R., Thompson, P.M., Holmes, C.J., Batth, R., Jernigan,T.L., & Toga, A.W. 
(1999).  Localizing age-related changes in brain structure between childhood and 
121 
 
adolescence using statistical parametric mapping.  NeuroImage, 6, 587-597. 
doi:10.1006/nimg.1999.0436 
 
Sowell, E.R., Thompson, P.M., Tessner, K.D., & Toga, A.W. (2001).  Mapping 
continued brain growth and gray matter density reduction in dorsal frontal cortex:  
Inverse relationships during postadolescent brain maturation.  Journal of 
Neuroscience, 21, 8819-8829. doi: 0270-6474/01/218819-11  
 
Sowell, E.R., Peterson, B.S., Thompson, P.M., Welcome, S.E., Henkenius, A.L., & Toga, 
A.W. (2003).  Mapping cortical change across the lifespan.  Nature Neuroscience, 
6, 309-315. doi:10.1038/nn1008     
 
Spear, L.P.  (2000). The adolescent brain and age-related behavioral manifestations.  
Neuroscience and Biobehavioral Reviews, 24, 417-463.  doi:10.1016/S0149-
7634(00)00014-2 
 
Steinberg, L. (2005).  Cognitive and affective development in adolescence.  Trends in 
Cognitive Neuroscience, 9(2), 69-74.  doi:10.1016/j.tics.2004.12.005   
 
Tabachnick, B.G., & Fidell, L.S.  (2007). Using multivariate statistics (5
th
 ed.).  Boston:  
Allyn and Bacon.   
 
Thompson, P.M., Giedd, J.N., Woods, R.P., MacDonald, D., Evans, A.C., & Toga, A.W. 
(2000).  Growth patterns in the developing brain detected by using continuum 
mechanical tensor maps.  Nature, 414, 190-193. doi:10.1038/35004593 
 
Viikinsalo, M.K., Crawford, D.M., Kimbrel, H., Long, A.E., & Dashiff, C.  (2005). 
Conflicts between young adolescents with type 1 diabetes and their parents.  
Journal for Specialists in Pediatric Nursing, 10(2), 69-80.   
 
Vriezen, E.R. & Pigott, S.E. (2002). The relationship between parental report on the  
BRIEF and performance-based measures of executive function in children with 
moderate to severe traumatic brain injury.  Child Neuropsychology, 8(4), 296-303. 
doi:10.1076/chin.8.4.296.13505 
 
Walker, J.M & D’Amato, R.C.  (2006). Test review: Behavior Rating Inventory of 
Executive Function-Self-Report version.  Journal of Psychoeducational 
Assessment, 24, 394-399. doi:10.1177/0734282906288390 
 
Watkins, P.J., Drury, P.L., & Howell, S.L. (1996).  Diabetes and its management (5
th
 
ed.).  London:  Blackwell Science. 
 
Wechsler, D. (1991) Wechsler Intelligence Scale for Children (3rd ed.).  San Antonio, 
TX: The Psychological Corporation. 
 
122 
 
Wechsler, D. (1999) Wechsler Abbreviated Scale of Intelligence.  San Antonio, TX: The 
Psychological Corporation. 
 
Weinger, K., Butler, H.A., Welch, G.Q., & La Greca, A.M. (2005).  Measuring diabetes 
self-care:  A psychometric analysis of the Self-Care Inventory-Revised with 
adults.  Diabetes Care, 28(6), 1346-1352.  doi:10.2337/diacare.28.6.1346 
 
Weissberg-Benchell, J., Wirtz, P., Glasgow, A.M., Turek, J., Tynan, W.D., & Ward, J.  
(1995). Adolescent diabetes management and mismanagement.  Diabetes Care, 
18(1), 77-82. doi:10.2337/diacare.18.1.77 
 
Weissberg-Benchell, J., Wolpert, H., & Anderson, B.J. (2007).  Transition from pediatric 
to adult care:  A new approach to the post-adolescent young person with type 1 
diabetes.  Diabetes Care, 30(10), 2441-2446. doi:10.2337/dc07-1249 
 
Willcutt, E.G., Doyle, A.E., Nigg, J.T., Faraone, S.V., & Pennington, B.F. (2005).   
Validity of the executive function theory of attention-deficit/hyperactivity 
disorder: A meta-analytic review.  Biological Psychiatry, 57, 1336-1346. 
doi:10.1016/j.biopsych.2005.02.006 
 
Wolters, C.A., Yu, S.L., Hagen, J.W., & Kail, R.  (1996). Short-term memory and 
strategy use in children with insulin-dependent diabetes mellitus.  Journal of 
Consulting and Clinical Psychology, 64, 1397-1405. doi:10.1037/0022-
006X.64.6.1397 
 
Wysocki, T., & Gavin, L.  (2006). Paternal involvement in the management of pediatric 
chronic diseases:  Associations with adherence, quality of life, and health status.  
Journal of Pediatric Psychology, 31(5), 501-511. doi:10.1093/jpepsy/jsj042 
 
Wysocki, T., Greco, P., & Buckloh, L.M.  (2003). Childhood diabetes in psychological 
context.  In M.C. Roberts (Ed.), Handbook of pediatric psychology (pp.304-320).  
New York:  Guilford Press. 
 
Wysocki, T., Iannotti, R., Weissberg-Benchell, J., Laffel, L., Hood, K., Anderson, B., &  
Chen, R. (2008). Diabetes problem solving by youths with type 1 diabetes and 
their caregivers:  Measurement, validation, and longitudinal associations with 
glycemic control.  Journal of Pediatric Psychology, 33(8), 875-884. 
doi:10.1093/jpepsy/jsn024 
 
Wysocki, T., Linschied, T.R., Taylor, A., Yeates, K.O., Hough, B.S., & Naglieri, J.A.  
(1996).  Deviation from developmentally appropriate self-care autonomy.  
Diabetes Care, 19, 119-125. doi:10.2337/diacare.19.2.119 
 
Yakovlev, P.A. & Lecours, I.R.  (1967). The myelogenetic cycles of regional maturation 
of the brain.  In A. Minkowski (Ed.), Regional development of the brain in early 
life (pp. 3-70).  Oxford:  Blackwell.   
123 
 
Youniss, J.,& Smollar, J.  (1985).  Adolescent relations with mothers, fathers and friends.  
Chicago, IL:  University of Chicago Press. 
 
Zelazo, P.D., Carter, A., Reznick, J., & Frye, D.  (1997). Early development of executive  
function:  A problem-solving framework.  Review of General Psychiatry, 1(2), 
198-226. doi:10.1037/1089-2680.1.2.198 
